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ABSTRACT
Cytochrome P450 (P450 or CYP) catalysis involves the oxygenation of organic
compounds via a series of catalytic intermediates, namely, the ferric-peroxo, ferrichydroperoxo, Compound I (Cpd I), and FeIII(H2O2) intermediates. The general
consensus is that the Cpd I intermediate is the most reactive species in the reaction cycle,
especially when the reaction involves hydrocarbon hydroxylation. Other than Cpd I, there
is a multitude of evidence, both experimental as well as theoretical, supporting the
involvement of other intermediates in various types of oxidation reactions. In part I of
this work, the multiple oxidant hypothesis of P450 catalysis has been probed using P450CAM from Pseudomonas putida, a prototypical P450 enzyme. P450-CAM is a versatile
catalyst that has been shown to catalyze many typical P450 reactions in camphor analog
substrates. The active site threonine-252 to alanine (T252A) mutant of P450-CAM on
reaction with camphor yields H2O2 and minimal oxidized camphor, presumably because
it makes very little Compound I while still generating the ferric-peroxo and ferrichydroperoxo species. This makes T252A P450-CAM an ideal catalyst to probe the
multiple oxidant hypothesis. Using heteroatom-containing substrates, including camphor
analog substrates modified at the fifth position, we have compared the quantitative
product formation between WT and T252A P450-CAM to gain an insight in the multiple
oxidant hypothesis.
Magnetic circular dichroism (MCD) spectroscopy also known as the Faraday
effect, is an excellent fingerprinting tool of various heme systems.
vi

It can be used for assigning axial ligand identity, coordination numbers as well as spin
state determination of the heme iron, which can lead to important information about their
structures and functions. In part two of this work, we present results from the application
of MCD spectroscopy in the axial ligand(s) identification analysis of three novel heme
proteins, sGAF2, Z-ISO and Phu_R, and in the characterization of the dioxygen complex
of an engineered P450BM3 protein.
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CHAPTER 1
OXIDIZING INTERMEDIATES IN P450 CATALYSIS:
A CASE FOR MULTIPLE OXIDANTS1

Anuja R. Modi and John H. Dawson, accepted for publication in Monooxygenase,
Peroxidase and Peroxygenase Properties of Cytochrome P450 Enzymes and their
Mechanisms of Action. 5/23/2014.
1
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Abstract:
Cytochrome P450 (P450 or CYP) catalysis involves the oxygenation of organic
compounds via a series of catalytic intermediates, namely, the ferric-peroxo, ferrichydroperoxo, Compound I (Cpd I) and FeIII(H2O2) intermediates. Now that the
structures of P450 enzymes have been well established, a major focus of current research
in the P450 area has been unraveling the intimate details and activities of these reactive
intermediates. The general consensus is that the Cpd I intermediate is the most reactive
species in the reaction cycle, especially when the reaction involves hydrocarbon
hydroxylation. Cpd I has recently been characterized experimentally. Other than Cpd I,
there is a multitude of evidence, both experimental as well as theoretical, supporting the
involvement of other intermediates in various types of oxidation reactions. The
involvement of these multiple oxidants has been experimentally demonstrated using P450
active-site mutants in epoxidation, heteroatom oxidation and dealkylation reactions. In
this chapter, we will review the P450 reaction cycle and each of the reactive
intermediates to discuss their role in oxidation reactions.
1.1

Introduction
Cytochrome P450 enzymes are heme-thiolate ligated monooxygenases that are

ubiquitous in the biological kingdom and catalyze a variety of oxidation reactions
covering a wide range of substrates.1, 2 Hemeproteins are classified as P450s when their
FeIICO complex has a maximum Soret absorbance at 450 nm.3 P450s were discovered
five decades ago because of their important role in xenobiotic clearance from the human
body, but the interesting nature of their chemistry has attracted attention from chemists,
biochemists, biophysicists, structural biologists and now even biotechnologists. Oxygen
2

activation is central to life as spin forbiddance makes ground-state triplet molecular
oxygen by itself inert toward organic molecules.4 Living beings therefore use enzyme
systems for oxygen activation to perform biologically important reduction-oxidation
(redox) reactions. P450s are one of the metal-containing oxygenases that utilize
molecular oxygen to stereo- and regioselectively oxygenate substrates under
physiological conditions. While P450s are capable of diverse reactions, they are in fact
mostly known for their ability to catalyze the oxidation of inert substrate CH bonds
under physiological conditions. To put into perspective, the bond strength of a typical
secondary CH bond is about 101 kcal mol.1

5

Present understanding of the P450

catalytic mechanism has been developed over the course of the last four decades by
advances in genomics, molecular biology and spectroscopy.6 Comparison with analogous
heme oxygen activation systems has also greatly contributed to our current understanding
of its mechanism. Knowledge of the P450 intermediates is now being used for
development of efficient inorganic catalysts for laboratory and commercial use.7
Alternatively, in biotechnological setups, P450s are being modified to catalyze
stereoselective oxidation reactions.8
Oxidation of substrates by P450 can be summarized by the following equation:

The catalytic mechanism of P450s occurs in a cyclic fashion involving systematic
generation of intermediates, some of which are transient.9 Electrons for this oxidation
reaction are provided by NAD(P)H and are shuttled to the P450 active site with the aid of
reductase enzymes. Protons are donated by water molecules in the active site. Based on
associated redox systems, P450s can be classified as type I or type II as shown in

3

Scheme. 1.1.10 Type I P450s are mainly the mammalian mitochondrial and bacterial
P450s, which utilize a flavoprotein to transfer electrons to P450s via an intervening ironsulfur cluster protein (Fe2S2). Type II P450s are the mammalian xenobiotic-metabolizing
enzymes that receive electrons via FAD- and FMN-containing reductases. There are
certain exceptions such as P450BM3 in which the heme and FMN/FAD-containing
reductase domains are part of a single polypeptide that functions as a self-sufficient
unit.11, 12
NAD(P)H + H+
Class I

FAD

Fe2S2

P450

FAD

FMN

P450

NAD(P)+
NAD(P)H + H+
Class II
NAD(P)+

Scheme 1.1 Electron transfer chains in class I and class II of P450 enzymes, see Ref. 10.
1.2

The P450 Catalytic Cycle
P450-CAM (CYP101) is a bacterial P450 enzyme from Pseudomonas putida that

converts 1R-(+)-camphor to 5-exo-hydroxycamphor. This enzyme is soluble and
therefore easy to purify and was the first P450 whose crystal structure was solved.13
Since then, its structure has been extensively studied and it has served as a prototype for
structure-function studies of the entire P450 family. The reaction cycle for P450-CAM
also holds true for the entire P450 family. The putative catalytic mechanism of P450s in
which the substrate RH is oxidized to R-OH in a series of steps is shown in Scheme. 1.2.
The catalytic cycle begins with the reversible substrate binding to the water-coordinated
low-spin (S=1/2) resting state of the ferric enzyme (Scheme. 1.2, 1). Substrate binding
4

causes displacement of water as the sixth ligand to the heme with formation of the highspin (S=5/2) pentacoordinate enzyme-substrate adduct (Scheme. 1.2, 2). This causes the
midpoint redox potential of the heme to shift to a more positive value (from 330 mV to
173 mV).14 The sharp shift in the reduction potential resulting from substrate binding
enables electrons to flow from NAD(P)H to the P450 enzyme via an associated reductase.
The first electron generates the reduced ferrous-substrate adduct (Scheme. 1.2, 3).
Subsequent binding of dioxygen generates the oxyferrous complex or a resonancestabilized ferric superoxide complex Fe+3-OO, a η1 superoxide radical anion
coordinated to the ferric heme center with an unpaired electron on the terminal oxygen
atom (Scheme. 1.2, 4).15 The second electron from NAD(P)H then reduces the oxyferrous
complex resulting in the Fe+3-OO (Scheme. 1.2, 5) ferric-peroxo intermediate. This is
also the rate-limiting step. Protonation of this intermediate leads to the Fe+3-OOH
(Scheme. 1.2, 6) ferric-hydroperoxo intermediate, also known as Compound 0 (Cpd 0). A
second protonation of this intermediate leads to OO bond heterolysis forming the highly
transient and reactive porphyrin π radical cation ferryl complex (Scheme. 1.2, 7) known
as Cpd I. Cpd I derives its name from the analogous high-valent Cpd I species of heme
peroxidases.16,

17

According to the now well-accepted mechanism for hydrocarbon

hydroxylation, Cpd I abstracts a H atom from the substrate resulting in a ferryl hydroxyl
intermediate (Scheme. 1.2, 8) known as protonated Compound II (Cpd II) and a substrate
radical. In what is known as the oxygen rebound, the hydroxyl moiety on the iron
combines with the substrate radical to give the hydroxylated product, while the enzyme
returns to its resting ferric state.
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Scheme 1.2 Reactive intermediates and shunt pathways in the catalytic cycle of P450
enzymes.
In addition to the normal catalytic pathway, there are three uncoupling reactions
within the cycle that lead back to the enzyme-substrate adduct without any product
formation. The first is the auto-oxidation of the oxyferrous enzyme with simultaneous
generation of a superoxide anion (Scheme. 1.2, I). In the second shunt pathway, the
hydroperoxo anion dissociates from the ferric-hydroperoxo intermediate (Scheme. 1.2,
II). Heterolytic cleavage of the OO bond is critical for Cpd I formation. Incorrect
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protonation at the distal oxygen generates the Fe+3-H2O2 intermediate (Scheme. 1.2, 9)
followed by dissociation of hydrogen peroxide without substrate turnover. This pathway
is often seen in the active-site alcohol-alanine mutant.18 In the oxidase shunt (Scheme.
1.2, III), the ferryl intermediate is reduced to water in lieu of substrate oxidation. In an
alternative pathway to the normal reaction cycle, the enzyme can be turned over without
the nucleotide-reducing equivalents via the peroxide shunt (Scheme. 1.2, IV). Cpd I can
be generated from this pathway using oxygen atom donors such as peracids, peroxides
and iodosobenzene.19-21
1.3

Nature of the P450 Active Site
There

are

over

20,000

known

CYP

genes

(http://drnelson.uthsc.edu/CytochromeP450.html). P450s share their catalytic capabilities
with other heme-containing enzymes, catalases, peroxidases and oxygenases, but they are
all very different structurally. The architecture of the active site in P450s plays an
important role in the sequential generation of intermediates in the catalytic cycle. For a
complete understanding of P450 monooxygenation chemistry, the majority of research
has focused on the factors influencing electron delivery and dioxygen binding to the
heme iron, proton addition to the bound dioxygen in the distal pocket of the heme and
cleavage of the OO bond. Residues most important for oxygen activation are the heme
proximal cysteine ligand (Cys357 in P450CAM) and the acid-alcohol pair in the distal
pocket of the heme (Thr252-Asp251 in P450CAM). These amino acids are conserved in
the active site of almost all P450s. Since the active site is hydrophobic, a chain of water
molecules provides access to bulk solvent outside and is held in place by H-bonding to
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each other and to the alcohol residue in the active site (Thr252 in P450CAM).22 The
active site of camphor-bound oxy-P450-CAM is shown in Figure. 1.1.
In this landmark work, Schlichting and coworkers structurally characterized the
oxyferrous complex of P450CAM using cryocrystallography.
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Important residues

involved in oxygen activation were Cys357, Asp251, Thr252 as well as the bound
camphor substrate and are shown in Fig. 3. The hydroxyl group of Tyr96 H-bonds to the
keto group of camphor to orient the site of oxygenation above the heme. The water
molecules Wat901 and Wat902 seen in the active site are implicated as the source of
protons required for formation of the active Fe IV=O species. Accordingly, the Thr252 Hbonds to Wat901, which serves as the H-bond donor to the distal oxygen atom of the
heme-bound dioxygen in P450CAM.
1.3.1 Role of Cys as Proximal Heme Ligand
The heme in P450 enzymes is of the heme-b type, where the iron protoporphyrinIX is covalently linked to the protein backbone via a Fe-S bond to cysteine. In the case of
P450CAM, Cys357 serves as the cysteine residue as seen in Figure. 1.1. The proximal
cysteine thiolate ligand is indispensible for P450 catalytic activity and mutation of the
cysteine residue leads to loss of activity.23 In the P450 catalytic cycle, one electron
reduction of the oxyferrous state followed by protonation of the distal oxygen leads to the
ferric-hydroperoxo intermediate. A second protonation of the ferric-hydroperoxo
intermediate followed by heterolytic cleavage of the OO bond leads to formation of Cpd
I, which is the primary oxidant in the cycle. Maintaining the cysteine as a thiolate anion
on the proximal side of the heme at the same time as the iron in the ferrous state is crucial
for Cpd I generation.24
8

Figure 1.1 Active site of camphor-bound oxy-P450-CAM constructed using PDB file
1DZ8.9
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The thiolate anion is stabilized by H bonds from the protons of the adjacent residues, Leu
358 (3.5 Å), Gly 359 (3.3 Å), Gln 360 (3.3 Å). Mutation of these residues led to
distortion in H-bonding and an increase in the uncoupling of the ferric-hydroperoxo
intermediate.25, 26
Dawson and coworkers suggested that the polarizable nature of the cysteine
thiolate anion ligand provides a strong ‘push’ of electron density via the heme onto the
OO bond of the ferric-hydroperoxo intermediate, thus promoting heterolytic OO bond
cleavage.27, 28 Furthermore, the electron-donating nature of the thiolate ligand also helps
to stabilize the resulting Cpd I intermediate. This result is similar to the effect seen in
cytochrome c peroxidase that contains a partially deprotonated proximal histidine ligand,
wherein the imidazolate ‘push’ in concert with a ‘pull’ from the conserved distal His-Arg
amino acids lead to heterolytic cleavage of the OO bond to generate Cpd I.
1.3.2 Role of the Acid-Alcohol Pair in Oxygen Activation
An acid-alcohol pair that is highly conserved in almost all P450 enzymes aids
oxygen activation in the distal heme pocket. The alcohol in most cases is threonine or
serine and the acid can be aspartate or glutamate. In the case of P450CAM, these residues
are Asp251-Thr252. Given their highly conserved nature and proximity to the hemedioxygen binding site, the role of this acid-alcohol pair in catalysis has been examined in
several mutagenesis studies. Specifically, the role of Thr was investigated by changing
the residue to Ala. In P450CAM, the Thr252Ala mutant was almost completely
uncoupled, leading to normal NADH and O2 consumption but essentially no product
formation.18, 29 Based on this result in P450CAM and other P450s as well,30, 31 the alcohol
residue is thought to stabilize water molecules in the active site by H-bonding during
10

substrate oxygenation.18, 29, 32 Ishimura and coworkers demonstrated that the uncoupling
reaction is promoted when the Thr in P450CAM is mutated to a Ser or Asn, thereby
ascertaining the role of Thr in stabilizing the H-bonding network in the distal pocket and
controlling proton delivery to the distal oxygen of bound dioxygen.22 The Thr252Ser and
Thr252Asn mutant enzymes retained more than half of the hydroxylating capability of
the enzyme. The Thr252 residue also participated in H-bonding with the distal oxygen of
the oxyferrous-P450 complex in P450CAM.33 The high-resolution crystal structure of the
P450CAM Thr252Ala mutant showed a clearly perturbed H-bonding network and excess
water molecules in the active site.32 It is thought that this perturbation leads to uncoupling
due to incorrect delivery of the second proton to the proximal oxygen.34 Just as in
P450CAM, the Thr268 in P450BM3 has been shown to play an important role in
sustaining the proton pathway from the bulk solvent to the dioxy-bound heme. Mutation
of Thr268 to Ala also leads to uncoupling followed by reduced substrate oxidation.30, 35
Unlike the alcohol residue, the acid residue has an important role in electron
transfer following oxyferrous intermediate formation. In P450CAM, the mutagenesis of
Asp251 to Asn leads to decreased turnover in the mutant enzyme rather than
uncoupling.36,

37

The Asp251Asn mutant displays an increased kinetic solvent isotope

effect compared to the wild-type enzyme and a directly linear correlation to NADH
consumption on bulk proton concentration, indicating that the proton delivery pathway
has been modified in the Asp251Asn mutant.36 Structural analysis of the Asp251Asn
mutant reveals significant changes in the active site. The Asn251 and Lys178 side chains
rotate away from the active site and the Asn251 H-bonds to Asp182, causing open access
to the heme.36 The flexibility of the Asp251 side chain stabilized by electrostatic bonding
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plays an important role in dioxygen scission in P450CAM and suggests a similar role for
the conserved acid functionality in other P450 enzymes.
1.4

Multiple Oxidants in P450 Catalysis
Although the P450s are a single family of enzymes, the wide variety of substrates

oxidized by P450 is quite astounding. The catalytic cycle of P450s has been well
established based on P450CAM as the prototype. The key catalytic intermediates have
been detected and well characterized. Even the ferryl Cpd I intermediate, initially thought
to be too short lived to detect has now been well characterized.38 Despite the fact that this
intermediate has not been detected in the normal P450 catalytic cycle, it has been
observed in the peroxide shunt pathway and there is little doubt about its involvement in
substrate oxidation. While the ferryl Cpd I intermediate is thought to be the oxidant of
choice in most oxidation reactions, the nature of certain catalytic intermediates and
comparison with analogous reactions catalyzed in other enzyme systems make it difficult
to deny the existence of multiple oxidizing species in the catalytic cycle. As seen in
Scheme 1.3, several reaction intermediates other than Cpd I are thought to be capable of
catalyzing some oxidation reactions depending on the type of substrate.
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Scheme 1.3 Multiple P450 oxidants and types of reactions catalyzed.
1.4.1 The P450 Dioxygen Complex
In P450 enzymes, binding of dioxygen to the ferrous heme traps O2 for substrate
oxidation. This generates the ferrous-dioxygen complex (Fe+2-OO), which is in resonance
with the ferric superoxide complex (Fe+3-OO) (Fig. 2, 4). The binding constant of
dioxygen to P450CAM is 1.7 x 106 M1 s1 at 4o C.39 The oxyferrous complex of P450s is
not as stable as that of oxygen carrier proteins. In P450CAM, it is moderately stable in
the presence of camphor and auto-oxidizes back to the ferric state at the rate of 0.01 s1 at
room temperature.39, 40 The oxyferrous-P450 complex is similar to that of many of the
analogous hemeproteins such as myoglobin, hemoglobin, CPO, NOS, etc.41-44 The
oxyferrous stretching band of oxyferrous P450CAM as determined by resonance Raman
spectroscopy is 1141 cm1, which is typical for superoxide complexes.45 Using
cryocrystallization, the oxyferrous complex of P450CAM was determined at atomic
resolution. A representative figure is shown in Scheme 1.4.9
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Scheme 1.4 Oxyferrous complex of P450-CAM determined using PDB file 1DZ8.9
The oxygen is coordinated to the heme iron in a slightly bent fashion with the Fe-OO
angle being 142o. The oxyferrous complex is stabilized with the aid of a H-bond between
the distal oxygen and hydroxyl of the nearby Thr252 residue. While the oxyferrous
complex by itself is not known to catalyze any oxidation reaction, its formation is
necessary to generate the subsequent catalytic intermediates in the reaction cycle.
1.4.2 Ferric-peroxo Intermediate as a Nucleophilic Oxidant
Akhtar and coworkers first proposed a role for the ferric-peroxo intermediate in
the final step of oxidative deformylation catalyzed by lanosterol 14 -demethylase.46, 47
The enzyme catalyzes the oxidative deformylation of lanosterol, concomitantly forming
olefin in three oxidative steps, and each step utilizing a single equivalent of NADPH and
O2 as seen in Scheme 1.5. The final step results in cleavage of the C14C32 bond with
stereoselective removal of 15-H, resulting in the formation of a 14,15 double bond and
release of formic acid. The proposed mechanism involves homolytic cleavage of the O–O
bond in a peroxy-aldehyde adduct to give an alkoxy free radical that decays to the olefin
as a result of H abstraction by the simultaneously-created ferryl species.
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Scheme 1.5 Mechanism of oxidative deformylation catalyzed by lanosterol 14αdemethylase, see Ref. 47.
Similar mechanisms have also been proposed for demethylation in estrogen formation by
aromatase (CYP19A1) and in the CYP17A1-catalyzed CC bond scission of 17hydroxyprogesterone.47,

48

The formic acid formed in these P450-catalyzed oxidative

deformylations has been shown to retain the original carbonyl oxygen and hydrogen as
well as an atom from molecular oxygen, clearly pointing to the involvement of the ferricperoxo intermediate in the mechanism. In the CYP17A1 (17-hydroxylase-17,20lyase)catalyzed reaction, oxygen labeling experiments also point to homolytic scission
of the OO bond in the peroxo-substrate adduct.49 Vaz and coworkers analyzed the
elimination reaction of the aliphatic aldehyde in the rabbit drug-metabolizing CYP2B4
enzyme. These reactions also seem to corroborate the involvement of peroxy anionsupported homolytic scission, followed by fragmentation of the adduct into a carbon
radical and a formyl species that yields olefin products.50 Further evidence supporting

15

this mechanism is found when the carbon radical formed during the reaction inactivates
the heme in P450.51, 52
The electrophilic nature of aldehydes makes them easily susceptible to attack
from the nucleophilic peroxy anion. Such an example of nucleophilic attack is also seen
in nitric acid synthase (NOS) (Scheme 1.6). NOS is a heme-containing enzyme that
catalyzes the conversion of arginine to N-hydroxyarginine and then to citrulline and nitric
oxide. The second step of this reaction has been proposed to involve nucleophilic
addition of the ferric-peroxo species to the –C=NOH bond of the substrate.53 Inorganic
metalloporphyrins mimicking the ferric-peroxo intermediate have also been shown to
catalyze the deformylation, as well as epoxidation, of ,-unsaturated carbonyl groups.54,
55
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Scheme 1.6 Mechanism of oxidative deformylation catalyzed by NOS, see Ref. 53.
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1.4.3 The Ferric-hydroperoxo Intermediate as an Electrophilic Oxidant
The ferric-hydroperoxo intermediate has been proposed as an oxidant in catalysis
involving nucleophilic substrates. However, unlike in the case of the ferric-peroxo
intermediate, the hypothetical involvement of the ferric-hydroperoxo species in oxidative
catalysis is not supported by solid evidence. Given the electrophilic nature of most
substrates oxidized by P450s, Cpd I is the clear favorite oxidant in these cases due to its
high reactivity. The most compelling evidence for involvement of the ferric-hydroperoxo
intermediate was demonstrated via substrate oxidation by active-site mutants in P450s. In
P450CAM, the Thr252 alcohol side chain was mutated to Ala and the resulting
Thr252Ala mutant was unable to catalyze the hydroxylation of camphor. Instead, the
mutant was highly capable of accepting electrons from the nucleotide cofactor to convert
dioxygen to hydrogen peroxide (Scheme 1.2, II).18,

29

Improper protonation to the

proximal oxygen of the ferric-peroxo intermediate thus leads to uncoupling. This mutant
is, therefore, unable to form Cpd I but generates both the ferric-peroxo and ferrichydroperoxo intermediates. ENDOR spectroscopic analysis of the cryoreduced
Thr252Ala mutant shows a buildup of the ferric-hydroperoxo intermediate at 77 K.
Annealing at high temperatures yields the ferric enzyme but no hydroxylated product.56, 57
As such, the Thr mutant of several P450s has been used in the study of a number of
electrophilic oxidation reactions.
Vaz, Coon and coworkers were the first to study the effects of the active-site Thr
to Ala mutation in rabbit drug-metabolizing CYP2B4 and CYP2E1 enzymes using
various alkene substrates (Scheme 1.7).58 The researchers observed a decrease in allyllic
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oxidation of the alkenes. In contrast, the Thr303Ala mutation in CYP2E1 significantly
increased the rates of epoxidation compared to the wild-type enzyme.

O
OH

Scheme 1.7 Possible epoxidation reaction products in P450 enzymes.
On the other hand, the corresponding Thr302Ala mutant of CYP2B4 demonstrated
reduced rates of both allylic hydroxylation and epoxidation. Increased epoxidation versus
allylic hydroxylation was observed in the CYP2E1 Thr303Ala mutant and was construed
as evidence that epoxidation could be catalyzed by the ferric-hydroperoxo intermediate,
while decreased Cpd I formation led to decreased hydroxylation. However, failure to
observe similar results with CYP2B4 along with high quantities of hydroxylated product
made the data somewhat less reliable, apparently because Cpd I was still being generated
to a significant extent.
Dawson and coworkers, in collaboration with the Sligar laboratory, studied the
reactivity of the ferric-hydroperoxo intermediate in the Thr252Ala mutant of P450CAM
using the alkene epoxidation reaction. Unlike the CYP2B4 and CYP2E1 enzymes, the
Thr252Ala P450CAM mutant catalyzed the formation of less than 1% of the
hydroxylated product, thus providing a more robust system to analyze the presence of a
second oxidant, in this case the ferric-hydroperoxo intermediate. Both substrates were
easily oxidized to epoxides (Scheme 1.8) at a rate of ~1520% compared to that of wildtype P450CAM.59 These results substantiated the work of Vaz and coworkers regarding
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the involvement of a second electrophilic oxidant. Shaik and coworkers examined alkene
epoxidation in the context of the two-state reactivity theory involving Cpd I60,

61

and

proposed that the ferric-hydroperoxo species is a sluggish oxidant compared to the highly
reactive Cpd I species. The researchers concluded that the ferric-hydroperoxo species has
a large energy barrier to overcome, whereas ferric-hydroperoxo conversion to Cpd I is
barrierless.62 P450 reactivity also appears to be influenced by H-bonding to the proximal
thiolate ligand and polarity changes in the vicinity.62-64
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Scheme 1.8 Olefin epoxidation by P450 CAM, see Ref. 59.
P450 reactivity is also proposed to be influenced by changes in the relative amounts of
high-spin and low- spin Cpd I, rather than amounts of the ferric-hydroperoxo and Cpd I
species.62. However, the ‘two-state’ reactivity theory cannot clearly explain why the
Thr252Ala mutant does not hydroxylate camphor. If the Cpd I oxidizing species only
displays variation in the amounts of high-spin and low-spin states, the mutant enzyme
should have displayed significant hydroxylation activity.
The ferric-hydroperoxo intermediate has also been investigated as a potential
oxidant in heteroatom oxidations. Jones and coworkers have looked particularly at
sulfoxidation and N-dealkylation reactions utilizing P450BM3. Using clever substrate
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design and the Thr268Ala mutant, the researchers sought to test whether the two products
originated from the same oxidant species (Scheme 1.9).65 Thus, substrate 10a showed
four times increased sulfoxidation activity compared to N-dealkylation activity. Next, the
investigators used an isotopically-sensitive N-dealkylation substrate, 10b, to test the
premise that due to a large kinetic isotope effect (KIE), sulfoxidation activity would be
higher than N-dealkylation activity if both products arose from a single oxidant.
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Scheme 1.9 Heteroatom oxidation by P450 BM3, see Ref. 65.
However, a negligible KIE was observed leading to several possible conclusions: (1) both
products arose from different oxidants, (2) binding of substrate to the P450BM3 enzyme
caused an interchange in the position of substituents, thereby changing their position in
the catalytic site, and (3) the inherent KIE of N-dealkylation was very small. Using
substrate 11, the researchers were able to demonstrate the rapid interchange of
substituents at the end of the molecule. This result combined with an intramolecular KIE
for substrate 10c eliminated the last two possibilities, leading to the proposal that both the
N-dealkylation and sulfoxidation products arose from two different oxidants. The authors
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suggested that N-dealkylation was a product of Cpd I-mediated oxidation while
sulfoxidation likely involved the ferric-hydroperoxo intermediate, without eliminating the
possibility that the data could result from different forms of the same active oxygen
species i.e Cpd I. In accordance with the ‘two-state’ state theory, where the low spin and
high spin states form different enzyme-substrate (ES) complexes, the N-dealkylation and
sulfoxidation reactions products can result from two non-interchangeable ES
complexes.63, 65 Watanabe has also proposed that the altered reactivity in the active site
threonine to alanine mutants may be a result of the altered water molecule network in the
active site, which affects the hydrogen bonding of the Cpd I-ES complex.66 This
alteration can skew the ratios of the low spin and high spin state of Cpd I, thereby
affecting the mutant reactivity.
The ferric-hydroperoxo species has also been implicated as an oxidant in
hydrocarbon hydroxylation reactions. Catalysis by the ferric-hydroperoxo species was
proposed to involve a cationic protonated alcohol intermediate67 (Scheme 1.10) as
opposed to a radical intermediate formed in the radical rebound pathway (Scheme 1.2).
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Scheme 1.10 Proposed hydrocarbon hydroxylation mechanism by the ferric-hydroperoxo
species, see Ref. [67,68].
Newcomb and coworkers used ‘radical clock’ experiments to provide evidence for
involvement of a cationic intermediate.67-71 In the first of such studies, the oxidation of
trans-1-methyl-2-(4-trifluoromethyl)-phenylcyclopropane was examined. The substrate
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could be oxygenated either on the methyl group yielding methyl alcohol as an
unrearranged product or on the phenyl ring giving a ring-opened alcohol as a rearranged
product. Using CYP2B1 as a biocatalyst, the substrate 12b was shown to generate a ringopened product, characteristic of a cationic rearrangement pathway (Scheme 1.11).72
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Scheme 1.11 Radical clock probes for mechanistic elucidation in CYP2B4, see Ref. 72.
Reaction of substrate 12a with the CYP2B4 Thr302Ala mutant enzyme showed a mixture
of products, both unrearranged and rearranged methyl oxidation as well as phenyl ring
oxidation products. There was little difference in the ratio of rearranged to unrearranged
product between the wild-type and mutant enzyme. However, a higher ratio of phenyl
oxidation was seen in the mutant enzyme. The authors suggested that this result clearly
indicated an alternative oxidant at play in the mutant enzyme that preferred the easier
phenyl ring oxidation. To suppress phenyl ring oxidation in substrate 12b, the phenyl ring
was replaced with an electron withdrawing CF3 group, which produced an altered ratio
between the ring-opened and ring-closed products. This intimated a change in the oxidant
in the hydroxylation reaction for that substrate. While these results satisfyingly conveyed
involvement of the ferric-hydroperoxo species in the hydroxylation of certain substrates,
the species is indeed a sluggish oxidant whereas Cpd I appears to be the oxidant of choice
in hydrocarbon hydroxylations.61 While the ferric-hydroperoxo species appears in almost
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all heme-based oxygen activation enzymes, there are a few examples where it plays a
primary role in substrate oxidation. For example, heme oxygenase catalyzes the oxidation
of heme to biliverdin73 and the first step of this oxidation involves an -mesohydroxylation of the heme group that is thought to be catalyzed by an electrophilic
oxidant, most likely, the ferric-hydroperoxo intermediate.74-76
1.4.4 Cpd I as the Most Powerful Oxidant
The mechanism of oxidation in P450s has been established by comparison with
other heme-based oxygen activating enzymes as well as spectroscopic characterization of
the reaction intermediates. P450s are similar to other metalloenzymes such as NOS and
chloroperoxidase (CPO) in that they all have heme coordinated to a cysteine thiolate
ligand. P450s and NOS are oxidoreductases that activate molecular oxygen.77,

78

The

P450s have long been presumed to oxidize substrates via a reactive porphyrin radical
cation ferryl species known as Cpd I. Additional evidence for reactive intermediates was
also collected by direct observation through a combination of various spectroscopic
techniques.79 Based on the observed activation of P450s by hydrogen peroxide, alkyl
hydroperoxides, periodate and iodosobenzene, oxygen activation was assumed to occur
by a two-electron reduction of dioxygen to the level of H2O2 followed by formation of the
ferryl

intermediate

as

seen

in

heme-containing

peroxidases.80

Synthetic

metalloporphyrins could form a porphyrin radical cation (ferryl) species at low
temperature in polar medium on reaction with peroxy acids and this intermediate had the
reactivity to insert an oxygen atom into hydrocarbon substrates (Scheme 1.12).81
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Scheme 1.12 Cpd I formation in synthetic metalloporphyrins by peroxy acids,
reproduced with permission from Groves, J. T. (2003) The bioinorganic chemistry of iron
in oxygenases and supramolecular assemblies, Proc. Natl. Acad. Sci. U. S. A. 100, 35693574, Copyright 2003 National Academy of Sciences, U.S.A.
When the transfer of an oxygen atom from the peroxy acid to produce the ferryl
intermediate occurs, then the substrate is referred to as an ‘oxygen-rebound’ substrate.82
Cpd I has been well characterized in CPO83 and was thought to be elusive in P450s.
However, recently, Green and coworkers were successfully able to directly observe Cpd I
in CYP119A1 for the first time.38 Cpd I was formed in about 75% yield by the reaction of
ferric CYP119A1 with m-chloroperbenzoic acid. The resulting Cpd I species could then
hydroxylate CH bonds in lauric acid with an apparent rate constant of kapp = 1.1 x 107.
The Mossbauer spectrum of this Cpd I species was similar to that seen using Cpd I of
CPO. The mechanism of oxygen transfer from Cpd I to form the hydroxylated product
has been a hotly debated topic. The initially proposed concerted mechanism of oxygen
insertion84 fell aside in favor of the two-step H atom abstraction/oxygen rebound
mechanism82. As explained in subsection 4.3, the ferric-hydroperoxo intermediate has
also been implicated as an oxidant in a few hydrocarbon hydroxylations. ENDOR
spectroscopic studies with cryoreduced wild-type P450CAM and its active-site mutants
provided compelling evidence in favor of H atom abstraction/hydroxyl rebound.57 Active
oxidant species of P450CAM were prepared by cryoreduction at 77 K of the oxyferrous
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intermediate in the P450CAM-camphor complex. The ferric-peroxo and ferrichydroperoxo intermediates were observed upon slowly warming to 119 K and were
subsequently characterized by EPR and ENDOR spectroscopy. Around 200 K, the ferrichydroperoxo species was quantitatively converted to 5-exo-hydroxycamphor, the natural
product of camphor hydroxylation. While the ferryl intermediate was not observed
directly, this oxidation was assumed to proceed through the hydroxyl intermediate
because of the following observations in the experiment. After formation of the ferrichydroperoxo species upon slowly warming of the sample, the first species observed had
the hydroxyl group bound to the heme iron, as was expected for the H atom abstraction in
the ferryl-involved mechanism. Had the ferric-hydroperoxo species been involved in the
oxidation, it would have initially formed hydroxycamphor via hydroxy insertion of the
distal oxygen atom of the ferric-hydroperoxo species. Hydroxycamphor would be
required to displace the hydroxyl/water that was bound to heme, but this displacement
reaction was implausible to occur at 200 K. Furthermore, ENDOR spectroscopy showed
that the hydrogen attached to the hydroxyl oxygen in the hydroxycamphor product
originated from the C-5 position of camphor, further supporting the ferryl mechanism.
Involvement of the ferric-hydroperoxo species would have required this H atom to
originate from the surrounding solvent.
Shaik and coworkers examined the mechanism of hydrocarbon hydroxylation
using theoretical calculations and proposed a two-state reactivity instead of two-oxidant
reactivity.85-88 The researchers showed that the porphyrin radical cation ferryl species
exists in two spin states, a quartet spin state and a doublet spin state that are close in
energy. Both species initiate the reaction by nearly identical H atom abstraction transition
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states. The species in the doublet state can quickly collapse to the product in a barrierless
reaction with no formation of an intermediate. This almost-concerted mechanism is aided
by the increased interaction of the cysteine thiolate ligand with the heme iron, the push
effect. On the other hand, the quartet state must overcome a significant energy barrier to
form the product, thus allowing formation and rearrangements of radicals if any. The
two-state reactivity model has provided a good explanation for the stereochemical
scrambling and structural rearrangement resulting from the radical clock experiments.
Direct observation and characterization of Cpd I has cemented the H atom
abstraction/hydroxyl rebound mechanism of P450 enzymes.89
1.4.5 FeIII(H2O2) as an Oxidant in Sulfoxidation Reactions
As described earlier, Jones and coworkers, based on the oxidation of a substrate
with both amine and thioether functional groups in P450BM3, proposed that two
different oxidants can be responsible for their oxidation. The ferric-hydroperoxo species
was proposed as the oxidant responsible for sulfur oxidation.65 In the same vein, De Voss
and coworkers analyzed the oxidation of thia fatty acids using P450BM3 (Scheme
1.13).90
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Scheme 1.13 Fatty acid oxidation by P450BM3, arrows indicate sites of oxidation and
stereochemistry of products formed, see Ref. 90.
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Analysis of the products indicated that presence of the thioether functionality
dramatically shifted the regiochemistry of the reaction. With substrates 13 and 14, the
oxidation was distributed across the last three methylene groups. However, replacement
of the second methylene group with sulfur resulted in the oxidation in 15 and 16
occurring exclusively at the sulfur. Interestingly, the sulfoxides were S enantiomers
whereas the alcohols were R enantiomers. While it was speculated that thioethers
undergo unusual binding to yield S sulfoxides, it has been shown in the past that modified
fatty acids undergo R oxidation exclusively.90-92 Substrates were also reacted with the
P450BM3 Thr268Ala active-site mutant, based on previous studies showing that the
mutant enzyme formed very little Cpd I and was able to accumulate the ferrichydroperoxo species.18,

29, 30

Despite the low turnover in the mutant for substrate 14,

product distribution and enantioselectivity remained unchanged between the wild-type
and mutant enzyme. This demonstrated that there occurred reduced Cpd I formation in
the mutant. For the thia fatty acid substrates, negligible change was observed in the
turnover, product distribution and enantioselectivity of the products between the products
of the wild-type and mutant enzyme. The authors proposed that sulfur oxidation must be
easily catalyzed by the ferric-hydroperoxo species, thereby enabling the mutant enzyme
to form comparable amounts of product compared to that of the wild-type enzyme.90
However, Shaik and coworkers have recently used theoretical calculations to
show that the FeIII(H2O2) complex (Scheme 1.2, 9) is a very efficient oxidant for
sulfoxidation reactions in P450s and iron corrolazine compounds.93 The FeIII(H2O2)
complex was shown to undergo a nucleophilic attack from the distal oxygen atom of the
peroxo complex resulting in heterolytic OO bond scission that is coupled to proton
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transfer (Scheme 1.14). The FeIII(H2O2) complex could also catalyze the oxidation on
sulfur much faster than could Cpd I. The ferric-hydroperoxo intermediate, in contrast,
had a high barrier via the homolysis pathway of oxygen insertion.93 This finding offers a
new paradigm for sulfoxidation reactions in P450s and their synthetic monologues.
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Scheme 1.14 Fatty acid oxidation by P450BM3, arrows indicate sites of oxidation and
stereochemistry of products formed, see Ref. 93.
1.5

Conclusions
The mechanistic complexity of P450 enzymes has been intensely debated for the

last few decades. The recent direct observation of P450 Cpd I and resulting studies of its
reactivity have provided strong support for the validity of the hydrogen atom
abstraction/radical rebound mechansim. The role of the ferric-peroxo intermediate as a
nucleophilic oxidant is also well established. The proposed role of the ferric-hyroperoxo
intermediate as an electrophilic oxidant remains to be established. Its role as an oxidant
has been proposed mainly based on turnover studies in P450 mutants with impaired
ability to form Cpd I. A recent addition to this oxidant puzzle is the Fe III(H2O2)
intermediate which has been proposed to be more active than Cpd I in thio-ether
oxidation reactions. The two-state reactivity theory involving Cpd I has also provided
some explanations for the disparate experimental data. Additional experimental and
theoretical data are still needed to provide further insights into the mechanisms of P450
catalysis.
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CHAPTER 2
PROBING HETEROATOM-CONTAINING SUBSTRATE OXIDATION IN P450-CAM
FOR NON-FERRYL REACTIVE INTERMEDIATES.
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Abstract:
The multiple oxidant hypothesis of P450 catalysis has been probed in this study
using P450-CAM from Pseudomonas putida, a prototypical P450 enzyme. The oxidation
of substrates is accomplished by a catalytic cycle via a series of intermediates generated
sequentially at the active site. Of these intermediates, the iron(IV)-oxo porphyrin radical
cation, also known as Compound I, is believed to be the ultimate oxidant. However
according to several studies in different types of P450s, it has been shown that the
peroxoferric and the hydroperoxoferric intermediates formed prior to the Compound I
may also be responsible for substrate oxidations depending on the reactivity of the
specific substrate. P450-CAM is a versatile catalyst that has been shown to catalyze many
typical P450 reactions in camphor analog substrates. The active site threonine-252 to
alanine (T252A) mutant of P450-CAM on reaction with camphor yields H2O2 and
minimal 5-hydroxycamphor, presumably because it makes very little Compound I while
still generating the peroxoferric and hydroperoxoferric species. This makes T252A P450CAM an ideal catalyst to probe the multiple oxidant hypothesis. Using primarily
electrophilic substrates, including camphor analog substrates modified at the fifth
position, we have compared the quantitative product formation between wild type (WT)
and T252A P450-CAM to gain an insight in the multiple oxidant hypothesis.
2.1

Cytochrome P450-CAM as Prototype
Much of the current information about P450s has been achieved through

extensive studies of P450-CAM from the camphor degrading bacterium Pseudomonas
putida. P450-CAM, the first soluble P450 was discovered by Gunsalus and co-workers.1
Later, Poulos and co-workers published its crystal structure, which provided important
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insight into the mechanistic details of the reaction cycle.2 Although P450-CAM shares
less than 30% sequence identity with other P450s, the all-important aspects of active site
are conserved in the enzyme.3 The active site lies buried deep within the protein with the
hydrophobic inner environment of the protein surrounding the heme macrocycle as well
as the substrate camphor. The conserved proximal cysteine residue C357, which tethers
the heme to the protein, and the conserved acid-alcohol pair, D251-T252 are seen in the
active site (Fig. 2.1A and B). The acid-alcohol pair has an important role to play in
formation of the catalytic cycle intermediates. In wild-type P450-CAM enzyme the T252
residue lies on the distal side of the heme and is implicated in the protonation of the outer
oxygen atom in the ferric hydroperoxo species that leads to water being formed as a
leaving group with concomitant formation of Compound I. In the mutant enzyme where
the active site threonine 252 was changed to alanine (T252A), the catalytic cycle has
been found to undergo a short circuit pathway (Scheme 2.1, A). In this case the second
protonation happens incorrectly on the proximal oxygen on the hydroperoxo ferric
intermediate leading to H2O2 formation. D251 is known to support the chain of water
molecules that supply protons to the active site. Alteration of the D251 residue leads to
change in the rate-determining step of the catalytic cycle.4
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A

B

Figure 2.1 A) Crystal structure of P450CAM showing the heme macrocycle (red) and the
substrate camphor (yellow) deep within the protein (blue) at the active site.5 B) Active
site of camphor-bound oxy-P450-CAM, showing conserved residues (Cys357, Glu366,
Thr252, Asp251 and Tyr96) in the active site. Image constructed in PyMOL using PDB
file 1DZ8. 6
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Scheme 2.1 P450 reaction cycle and intermediates. A non-productive uncoupling
pathway that involves species 9 is shown in the inside of the outer cycle.
2.2

The Multiple Oxidant Hypothesis in P450 Catalysis
The exact intermediate responsible for adding oxygen to the hydrocarbon

substrate has now been affirmatively shown to be Compound I; however the possibility
of existence of multiple oxidants in the catalytic cycle also has been under consideration
for past few years.7 Scientists have used various techniques such as electron
paramagnetic resonance, electron nuclear double resonance, electron absorption
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spectroscopy following cryoreduction of the oxyferrous enzyme, stopped flow rapid scan
experiments and rapid freeze-quench methods by mixing ferric enzyme with oxygen
atom donors, P450-like inorganic models and theoretical calculations to experimentally
characterize the catalytic cycle intermediates.8-11 In addition to Cpd I, scientists have
looked at the reactivity of the peroxoferric intermediate (Scheme 2.1, 5) in nucleophilic
reactions and the hydro-peroxoferric intermediate (Scheme 2.1, 6) in electrophilic
reactions as shown in Scheme 2.2.
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Scheme 2.2 Multiple oxidants in the P450 reaction cycle and types of reactions catalyzed
by them.
Apart from reaction intermediates, Shaik and co-workers have proposed that the
two states of Cpd I intermediate, i.e the high-spin and low-spin forms, are responsible for
different reactions.12 While the peroxoferric intermediate involves a nucleophilic role for
P450 enzyme, most of the reactions catalyzed by P450s are electrophilic reactions in
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nature. Based on the turnover experiments of camphor, the T252A mutant of P450CAM
has shown to be ineffective at catalyzing the hydroxylation of camphor, Table 2.1.
Table 2.1 Amounts of 5-exo-hydroxycamphor formed during turnover of WT and T252A
P450-CAM with camphor, indicated as nmol product formed per nmol of P450 per min.

P450-CAM
1-R-camphor

WT
1170.7 ± 2

T252A
21.2 ± 3.6

% of WT
~ 1.8

In this study T252A P450CAM formed less than 2% of the oxidized product as
compared to the WT. The T252A variant however, is capable of accepting electrons from
NADH and reducing bound dioxygen to H2O2 (Scheme 2.1, pathway A).13 This indicates
that the T252A mutant is essentially incapable of forming Compound I and thus, is a
good system to study the reactivity of the preceding alternate non-ferryl oxidants. The
T252-A active site mutant of P450-CAM and analogous mutants of other P450s have
been widely studied to understand the role played by active site residues in dioxygen
activation and substrate oxidation mechanism.14-17 The Dawson lab in collaboration with
the Sligar lab first tested the reactivity of the T252A P450CAM mutant with camphor
alkene analogues to look for the presence of alternate oxidants.16 Reaction with alkene
substrates gave the corresponding epoxide products, however the rate of epoxidation was
only 15-20% of the rate at which the wild-type enzyme oxidized the substrate. The higher
rate of epoxidation as compared to that of camphor hydroxylation indicated that the
T252A mutant could utilize hydroperoxoferric intermediate for epoxidation, but that
Compound I remained the oxidant of choice in the wild-type enzyme for epoxidation. It
also indicated that the hydroperoxoferric intermediate is a rather sluggish oxidant.
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In order to further investigate the multiple oxidant hypothesis of P450 catalysis,
we have studied the reaction between other electrophilic substrates and T252A P450CAM enzyme in this study. The substrates include camphor analogues containing
reactive functional groups at C-5, which is the normal site of P450 catalyzed oxidation in
camphor, and the corresponding functional groups in benzene substrates. Reactions of
these substrates have been performed with both wild-type (WT) P450CAM as well as the
T252A mutant using the fully reconstituted electron transfer system consisting of NADH,
putidaredoxin (PdX) and putidaredoxin reductase (PdR). In this chapter, we report our
findings from the quantitative comparison of the product formation between the WT and
T252A to gain an insight into the multiple oxidant hypothesis.
2.3

Experimental Methods.

Expression and Purification of Proteins
a) WT and T252A P450-CAM: Both the WT and T252A P450-CAM enzymes were
purified according to protocol described in Dr. Glascock’s dissertation.18 TB1 stock cells
of E. coli bearing the pEMBL P450CAM containing plasmid were streaked on a LBAmpicillin agar plate and incubated over night at 37oC. A single colony from this plate
was used to inoculate a 100 mL of LB-Broth supplemented with ampicillin and the cells
are grown until the OD600 is about 0.8. 10 mL of this solution was then added to 6-L LBbroth supplemented with ampicillin and the cells are grown for 18 h. The cells are then
harvested by centrifugation at 4o C for 10 min at 5000 x g. The cells were finally washed
with buffer containing 1 mM 1R-(+)-camphor, 50 mM potassium phosphate (KPi) at pH
7.4 (buffer A). To purify the protein, the cell pellet was dissolved in buffer A as
described above in the washing step. The cell walls were broken by exposing them to 30
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s. sonication intervals at 90% output with 2 min interval between sonication, while being
stored on dry ice to prevent denaturation of the protein. The lysed cell debris was
removed by centrifugation at 4o C for 25 min at 10000 x g. The supernatant was loaded
on a Whatman DE52 cellulose anion exchange column and washed with the 1 mM 1R(+)-camphor, 50 mM KCl, 50 mM KPi at pH 7.4 (buffer B). The protein was eluted by a
linear KCl gradient from 50-250 mM KCl in buffer B. The purity of each sample was
analyzed by measuring the UV-visible (UV-vis) absorbance at 391 nm over that at 280
nm, the higher the ratio, better is the purity. To achieve higher purity, the protein was
loaded onto a Biogel P-100 size exclusion column and eluted with 1 mM 1R-(+)camphor, 50 mM KCl, 50 mM KPi at pH 7.4 (buffer C). Fractions with UV-vis
absorbance ratio A(391)/A(280) values greater than 1.4 were used for experimental work.
Proteins in buffer B containing excess camphor were concentrated to ~1 mM, flashfrozen in liquid nitrogen and stored at -80o C.
b) PdR and PdX: Dr. Thomas Poulos (University of California, Berkeley, USA) kindly
provided overexpression systems for PdR and PdX enzymes. Expression and purification
of these proteins were achieved as per published protocols with minor modifications.19, 20
For both PdR and PdX, the cell lysis was achieved by sonication as described above for
P450-CAM. For PdX, the two-step column purification was achieved by first loading the
lysate on to a Whatman DE52 cellulose anion exchange column, followed by a Biogel P100 size exclusion column. Protein fractions with UV-vis absorbance ratio
A(412)/A(280) values between 0.48-0.5 were used for experimental work. For PdR, the
final step of column purification was achieved on a Biogel P-100 size exclusion column,
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and the protein fractions with UV-vis absorbance ratio A(280)/A(454) values of 7.0 or
less were used.
Turnover Experiments:
a) Camphor removal and buffer exchange: In order to perform turnover experiments, the
P450-CAM enzymes had to be stripped of camphor. This was achieved using a Biogel
P6DG desalting column equilibrated with 0.05 M MOPS buffer at pH 7.0, followed by
buffer exchange on another Biogel P6DG desalting column equilibrated with camphor
free buffer B. Successful removal of camphor was confirmed by a shift in the Soret
absorbance from 391 nm to 417 nm.
b) Substrates: Benzene derivative substrates, styrene and thioanisole were purchased
from Sigma-Aldrich. 5-methylenylcamphor was synthesized by Shengxi Jin.21 (1R)-5exo-thiomethoxycamphor was newly synthesized according to the methods described by
Kemnitzer

22

and Jin

21

with minor modifications as described in Scheme 2.3. All the

intermediates and the final products of the synthesis were monitored by 1H-NMR and
GC-MS and were confirmed by comparing with previously published data.
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Scheme 2.3 Synthetic scheme for (1R)-5-exo-thimethoxycamphor.
c) Catalytic turnover and NADH consumption experiments: Reaction mixtures were set
up in 50 mM KPi pH 7.4 buffer containing a mixture of the P450CAM-WT (0.5 µM),
PdX (10 µM), substrate (0.5 mM for camphor analogues and 1 mM for benzene
analogues), and NADH (1.0 mM). Catalase (5 µM, based on heme) was used for benzene
substrates. The reactions were initiated by adding PdR (4.0 µM). Reactions were carried
out for 15 min. for the camphor analog substrates and 30 min. for the benzene substrates
and were quenched by adding 1 mL CH2Cl2. Suitable internal standards were added to
the reaction mix before extracting the products. To measure the kinetic solvent isotope
effect (KSIE), the reaction was carried out in D2O KPi buffers (see above). Prior to the
reaction, the P450-CAM enzymes were allowed to acclimatize in the buffer for at least 30
min. To monitor the NADH consumption during thioether substrate oxidation, the
turnover reaction was conducted in a 0.5 cm quartz cuvette and the decrease in absorption
at 340 nm was monitored on Agilent UV-vis instrument.
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d) Calculation of product formed: Oxidized products were analyzed by GC-MS. The
amount of products formed was quantitated using standard curves of the oxidized product
and internal standard, 3-bromocamphor for camphor analog substrates and 4-tertbutylphenol for benzene substrates.
2.4

Results and Discussion
In the first set of turnover experiments (Scheme 2.4), we looked at the products of

the turnover reaction of 5-methylenylcamphor (Scheme 2.4, 10) and styrene (Scheme 2.4,
12), followed by (1R)-5-exo-thiomethoxycamphor (Scheme 2.4, 14) and thioanisole
(Scheme 2.4, 15) with the WT and T252A P450-CAM mutant enzymes. The two olefincontaining substrates formed epoxide products (Scheme 2.4, 11 and 13) as has been
demonstrated previously in WT P450-CAM.16, 23 However, of the two sulfur-containing
substrates, thioanisole formed a sulfoxide (Scheme 2.4, 17) while the camphor analogue,
[(1R)-5-exo-thiomethoxycamphor], underwent an oxidative dealkylation to form a ketone
product (Scheme 2.4, 15). The results of the turnover experiments are summarized in
Table 2.2 below. With the olefinic substrates, the rate of epoxidation of styrene in T252A
P450-CAM was observed to be about 25% of the rate seen in WT P450-CAM. This value
is similar to the results previously reported for camphor olefin.16 In similar reactions
conducted in mammalian P450s, Coon and co-workers have reported similar findings and
have proposed a mechanism involving the hydroperoxo intermediate in the epoxidation
reaction.15
Oxidation of the two thiomethoxy substrates however, provided the most
surprising results. Both in camphor analogue substrate (14) and benzene substrate (16),
the rate of substrate oxidation observed in the T252A mutant was greater than 50% the
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rate seen with WT enzyme. We then looked at the NADH consumption and calculated
the coupling and uncoupling data for the thiomethoxy substrates as shown in the Table
2.3 below.

5-methylenylcamphor

styrene
O

10

11

14

12

15

16

13

17

thioanisole

(1R)-exo-thiomethoxycamphor

Scheme 2.4 Products of turnover reactions with olefins and thioethers catalyzed by P450CAM.
Table 2.2 Amounts of products formed with WT and T252A camphor indicated as nmol
product formed per nmol of P450 per min.
Substrate

P450CAM-

P450CAM-T252A

22.9 ± 0.6a

Rate of product
formed by
T252A
compared to
WT
21.4 %

WT

5-Methylenyl-camphor

107.5± 0.2a

(10)
Styrene (12)

0.9 ± 0.2a

0.2 ± 0.1

24.4 %

5-(1R)-exo-Thiomethoxy-

3.35 ± 0.6

1.79 ± 0.3

53.5 %

2.14 ± 0.2

1.65 ± 0.04

68.4 %

camphor (14)
Thioanisole (16)
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a,

Amounts of product formed is in agreement with values published previously

Table 2.3 Amounts of NADH consumed by turnover of P450 CAM with (A) 5-(1R)-exothiomethoxycamphor (14) and (B) thioanisole (16) indicated as nmol NADH consumed
per nmol of P450 per min compared with the amount of oxidized product formed.
(A) 5-(1R)-exothiomethoxy-

P450-CAM WT

P450-CAM T252A

NADH consumed

61.4 ± 1.8

61.8 ± 2.7

Product formed

3.35 ± 0.6

1.79 ± 0.3

Coupling %

5.6 ± 1

2.9 ± 0.6

Uncoupling %

94.5 ± 1

97.1 ± 0.6

P450-CAM WT

P450-CAM T252A

NADH consumed

44.8 ± 0.6

12.23 ± 2.8

Product formed

2.41 ± 0.2

1.65 ± 0.04

Coupling %

5.4 ± 0.5

13.9 ± 2.6

Uncoupling %

94.6 ± 0.5

86.0 ± 2.6

camphor (14)

(B) Thioanisole (16)

Sulfoxidation was exclusively observed for thioanisole (16). Consistent with
previously reported results, thioanisole was never observed to undergo S-dealkylation of
the methyl group attached to the sulfur group.24 In the sulfoxidation reaction, the T252A
mutant underwent oxidation at about 70% of the rate observed for that of the WT. It has
been recently proposed by Shaik and co-workers that the FeIII-(H2O2) (9 in Scheme 2.1)
complex could be a highly efficient oxidant in sulfoxidation reactions.25 The reaction has
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been proposed to occur by a nucleophilic attack from the distal oxygen atom of the Fe III(H2O2) complex resulting in heterolytic OO bond scission that is coupled to proton
transfer as shown in Scheme 2.5
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Scheme 2.5 Proposed mechanism of sulfoxidation by the FeIII(H2O2) intermediate.25
It is to be noted that the FeIII-(H2O2) complex is formed in the uncoupling pathway
thereby correlating with the observed high turnover despite low NADH coupling in
thioanisole sulfoxidation. Although Shaik and co-workers have proposed that FeIII-(H2O2)
intermediate is more efficient than Cpd I in thioether oxidation, the higher rate of
sulfoxidation by the WT enzyme suggests that Cpd I is still the strongest oxidant at play.
Oxidation at the sulfur atom was not observed in the thiomethoxy camphor
substrate (14). The reaction with the camphor analog is presumed to occur in two steps,
first C-hydroxylation followed by S-demethylation (Scheme 2.6). The hydroxylated
intermediate is too unstable to be observed and has never been seen as a detectable
product in our turnover reactions. The T252A mutant is able to oxidize the substrate at a
rate that is 60% of that seen with WT. For the camphor analogue, a higher coupling is
observed in the WT enzyme, although the coupling in the mutant enzyme is only reduced
by half despite forming product at a rate equal to 60% seen with the wild type.
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in

5-(1R)-

Since the first step of this oxidation is C-hydroxylation, if Cpd I was the oxidant of
choice, oxygen insertion would occur by the hydrogen atom abstraction-hydroxyl radical
rebound mechanism. Davydov and co-workers have shown that little camphor
hydroxylation in T252A proceeds via the ferryl intermediate,26 thus the higher
hydroxylation rate in the T252A mutant as seen in our data strongly indicates that
alternative oxidant(s) may be involved in reactions catalyzed by the mutant. The
theoretical examination of the bond energies of the 5-(1R)-thiomethoxycamphor structure
show that the presence of sulfur atom significantly weakens the C-H bond thus making it
susceptible to attack from weaker oxidants as well (Shengxi Jin, Feng Xu, Vitaly
Rassolov, John Dawson unpublished data).
Given the electrophilic nature of these reactions, and the high rate of reaction with
the T252A mutant which forms little Cpd I, either the ferric-hydroperoxo or FeIII(H2O2)
species are likely to be involved in the oxidation. The FeIII(H2O2) species has been
proposed to perform oxidation faster than it converts to Cpd I, thereby bypassing Cpd I in
presence of thioether,25 although the camphor thioether analog does not undergo
sulfoxidation. If the FeIII(H2O2) species is involved in the oxidative dealkylation and
were to proceed by O-O cleavage, we hypothesize the hydroxyl insertion mechanism
shown in Scheme 2.7 below.
58

O

-H2O

O

-H+

SMe

O

+OH

O

SMe

SMe

H
HO

H+

O

O

O H

2

:B
H

FeIII
9

Scheme 2.7 Putative mechanism for oxidative demethylation
thiomethoxycamphor reaction involving FeIII(H2O2) intermediate.
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Similarly, if the ferric-hydroperoxo was the involved in oxidation, the mechanism
could occur by insertion of the distal oxygen to form protonated alcohol, followed by loss
of proton to give a thio-hemiketal type intermediate. Loss of methanethiol results in
formation of ketone product. This mechanism is summarized in Scheme 2.8 below.
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Scheme 2.8 Putative mechanism for oxidative demethylation
thiomethoxycamphor reaction involving ferric-hydroperoxo intermediate.
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Involvement of ferric-hydroperoxo intermediate in hydrocarbon hydroxylation has been
unconvincing due to lack of compelling evidence. So far in nature, the only evidence for
direct involvement of ferric-hydroperoxo species in oxidation has been shown in the
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oxidation of heme to biliverdin by the heme oxygenase (HO) enzyme.27 However the lack
of well-defined catalytic residues in the HO active site have led to the proposal that such
HO catalyzed oxidations may be an exception in cases where O-O bond scission to yield
Cpd I is inefficient,27, 28 like in threonine to alanine mutations of P450s active sites.
2.5

Conclusions
The involvement of multiple oxidants in P450 catalysis stems from the idea of

‘induced reactivity’ in which the substrate modulates the properties of a reactive
intermediate.29 In this work, we have demonstrated that compared with the WT enzyme,
the T252A P450-CAM mutant exhibits considerable reactivity toward heteroatom
containing substrates. It is especially notable that in the case of thioether substrates, the
relative oxidation rates are close to 50% the rate seen with the wild-type enzyme. Since
the T252A P450-CAM mutant has almost no hydroxylation activity toward camphor, it is
presumed to form little if any Cpd I and therefore its ability to carry out substrate
oxygenations must be attributed to alternate reactive intermediates. In oxidation of the
benzene derivative substrate, thioanisole, theoretical calculations have shown that the
FeIII(H2O2) species can be an effective oxidant, even better than Cpd I. The involvement
of other oxidants, possibly ferric-hydroperoxo or FeIII(H2O2) is further affirmed in the
case of the T252A-camphor thioether substrate turnover as it undergoes hydroxylation
followed by demethylation. Once again, since this mutant does not form significant
amounts of Cpd I, its ability to carry out the S-demethylation reaction must be due to
involvement of another reactive intermediate, presumably the ferric-hydroperoxo species.
While the ferric-hydroperoxo intermediate may not be the oxidant of choice in the most
challenging oxidation reactions, the reactivity of this intermediate may be sufficient to
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oxygenate more reactive substrate such as the heteroatom-containing substrates examined
herein.
2.6
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CHAPTER 3
HEME IRON COORDINATION STRUCTURAL ANALYSIS USING MAGNETIC
CIRCULAR DICHROISM SPECTROSCOPY.2

Section 3.2 of this chapter was published as a part of MCD analysis in Bastian
Molitor, Samir El-Mashtoly, Anuja Modi, Marc Staßen, Christoph Laurich, Wolfgang
Lubitz, John H. Dawson, Michael Rother and Nicole Frankenberg-Dinkel. 2013. J. Biol.
Chem. 2013 288: 18458-18472.
2
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Abstract:
Magnetic circular dichroism (MCD) spectroscopy also known as the Faraday
effect is an excellent fingerprinting tool for various heme systems. It can be used for
assigning axial ligand identity, coordination numbers as well as spin state determination
of the heme iron, which can lead to important information about their structures and
functions. Over the past 30 years, the Dawson laboratory has recorded and maintained a
library of MCD spectra of numerous heme proteins from various collaborative projects
and their own studies. Continuing the collaborative work, in this chapter we present
results from the application of MCD spectroscopy in the axial ligand(s) identification
analysis of three novel heme proteins, sGAF2, Z-ISO and Phu_R, and in characterization
of the ferrous dioxygen complex of an engineered P450BM3 protein.
3.1

Magnetic Circular Dichroism Spectroscopy
Studies of the coordination structures of heme protein active sites provide

important information about the mechanism of action of the native heme proteins.
Particularly, the amino acids coordinating to the heme iron and those surrounding the
active site along with the oxidation and spin states of the heme iron have been shown to
play important roles in the structure and function of heme-proteins.1-3 Magnetic circular
dichroism (MCD) has long been used in the Dawson laboratory as a fingerprinting
technique for various heme systems. The theory of MCD is based on the Faraday effect
first discovered by Michael Faraday in 1845. Natural circular dichroism (CD) and MCD
both measure the difference in absorption between left and right circularly polarized
light. In MCD a magnetic field is applied parallel to the direction of propagation of
light.4-8 CD, however, is observable only in optically active species that exhibit
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dissymmetry within the structure of the chromophore (chirality) or environment.
According to the Faraday effect, the application of a magnetic field parallel to the
direction of light induces optical activity due to Zeeman splitting. Therefore all species
can exhibit MCD spectra while only the optically active species can exhibit CD spectra.
Both CD and MCD signals can only be observed in the regions displaying
electronic band absorption. An MCD spectrum is composed of several bands arising from
different electronic transitions, and these bands are composed of three separate, ‘A’, ‘B’
and ‘C’ terms Fig. 3.1.9 ‘A’ terms are temperature independent and have a typical
derivative-shaped dispersion centered on the electronic absorption spectrum band. ‘A’
terms are seen only in those systems that demonstrate degeneracy in excited state that is
lifted by the applied magnetic field, also known as Zeeman splitting and as such they are
typically seen in spectra of systems exhibiting a three-fold or higher symmetry axis. ‘B’
terms arise from magnetic field-induced ground state and excited state mixing, typically
seen in systems with less than three fold symmetry. They are Gaussian-shaped and are
temperature independent similar to the ‘A’ terms. ‘C’ terms are temperature-dependent,
arising from magnetic field-induced lifting of ground state degeneracies. This causes the
‘C’ terms to be Gaussian-shaped centered on the electronic absorption band.10, 11
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Figure 3.1 Diagram illustrating the origin of the A, B, and C terms of a MCD spectrum,
reprinted with permission from Vickery, L. E. (1978) Spin states of heme proteins by
magnetic circular dichroism, Methods Enzymol. 54, 284-303.
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It has been shown that MCD is a powerful probe of the heme iron spin state,
oxidation state, and the identity of the heme iron axial ligand(s) while being relatively
insensitive to the surrounding factors other than the axial ligands.12, 13 MCD spectra can
be recorded over a range of temperatures, on dilute samples even in the micromolar range
(10-6 M) and on both diamagnetic and paramagnetic species.13, 14 Unlike the traditional
UV-visible (UV-vis) absorption spectra, which only have positive sign features, MCD
spectra have both positive and negative sign features, thereby presenting a finer
electronic structural detail of the system being investigated. This ‘fingerprinting’ capacity
combined with the intrinsic sensitivity to the electronic (and thus structural) aspects of
the chromophore being examined and relative insensitivity of environmental factors
makes MCD an extremely useful tool for coordination structural elucidation. MCD
spectroscopy’s potential applications include:
a)

To determine ground state magnetic properties such as spin state, g-values, zero

field splittings and magnetic coupling;
b)

To assign electronic transitions pertaining to the electronic structure of a

chromophore, including theoretical models;
c)

To resolve individual components of electronic spectra of proteins containing

several metal centers; and,
d)

To compare novel proteins to model systems or vice-versa to determine the active

site coordination structure with regards to ligands, spin state, oxidation state, geometry,
etc. Comparisons of the proteins can be made regardless of the protein conformation
effects.
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Having introduced the theory and basic uses of MCD spectroscopy, in this chapter
we will look at the application of MCD in the determination of axial ligand identity in
novel heme proteins, sGAF2, Z-ISO and Phu_R, and in the characterization of the
dioxygen complex of an engineered P450BM3 protein.
3.2

Part A: Axial Ligand Determination in sGAF2
The protein MA4561 from the methanogenic archaeon Methanosarcina

acetivorans was predicted to be a phytochrome-like photoreceptor mainly because of the
presence of a conserved cysteine residue in the first GAF domain.15 However the
recombinantly produced and purified protein was shown to not bind any known
phytochrome chromophores, instead UV-vis absorption spectroscopy revealed the
presence of a heme tetrapyrrole cofactor. The heme is covalently attached via one vinyl
side chain to cysteine 656 in the second GAF domain. Majority of the heme-based
sensors have a heme-b type non-covalently attached tetrapyrrole cofactor, but pyridine
hemochromogen assay revealed that the α-band maximum in MA4561 is at 553 nm. This
is typically seen in c-type cytochromes due to the saturation of only one heme vinyl
group, whereas the other stays unsaturated.16, 17 Functionally MA4561 has been proposed
to be a heme-based sensor kinase that is able to autophosphorylate methyl sulfide
methyltransferase depending on the heme redox state.18 In order to get a better
understanding of the heme co-ordination structure, Prof. Nicole Frankenberg-Dinkel
(Ruhr-University, Bochum, Germany) collaborated with our laboratory for MCD studies
of the heme domain containing MA4561 variant, sGAF2.
3.2.1 Methods:
Dr. Nicole Frankenberg-Dinkel provided us with the purified protein samples
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prepared as described in.18 MCD spectra were measured on a Jasco J815
spectropolarimeter fitted with a Jasco MCD-1B magnet at a magnetic field strength of
1.41 T at 4° C using a 0.2 cm path length quartz cuvette. Jasco software was used for data
acquisition and manipulation as reported previously.19 Because the molar absorptivity of
the pyridine hemochromogen of the heme in variant sGAF2-His6 (without imidazole
(Im)) could not be determined, concentrations of the sGAF2 samples were tentatively
determined based on an estimated value of ε = 115 mM-1 cm-1 (the value for ferric
cytochrome b5) for the Soret absorption peak (415 nm) of the Im complex of ferric
sGAF2 at pH 7.0. UV-vis absorption spectra were recorded on Cary 400 spectrometer,
before and after each MCD measurement to track sample integrity. sGAF2 protein
samples were studied in 50 mM sodium phosphate buffer containing 100 mM NaCl
(NaPi) at pH 7.0 and in 50 mM CAPS buffer at pH 10.0. The Im and tetrahydrothiophene
(THT) adducts were prepared by adding 2 and 14 mM Im and THT to the ferric protein,
respectively. The ferrous species of sGAF2 was prepared from ferric protein in the
presence or absence of exogenous ligands (Im and THT) by flushing a rubber septumsealed cuvette with nitrogen gas for about 10-15 min followed by the addition of a small
amount of solid sodium dithionite.
3.2.2 Results and Discussion:
MCD spectra of ferric and ferrous states of sGAF2 are shown in Fig. 3.2, where
the spectra of analogous states of horse heart myoglobin (Mb), horseradish peroxidase
(HRP) and cytochrome b5 (cyt b5) are overlaid for comparison. All of these three
proteins contain His-ligated heme (iron-protoporphyrin IX) prosthetic group. At pH 7.0
ferric sGAF2 exhibits MCD spectrum (solid line in Fig. 3.2 A) in the visible region (450
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– 700 nm) that is similar to that of ferric HRP (dashed line) and ferric Mb (dotted line), a
five-coordinate and water-ligated six-coordinate heme respectively. However, a closer
comparison of the trough intensities at ~640 nm indicates that the spectrum of ferric
sGAF2 is more similar to that of HRP than Mb. In the Soret region (350 – 450 nm), an
asymmetric MCD spectrum of ferric sGAF2 having a prominent peak at ~404 nm
(intensity ~7.5 M-1 cm-1 T-1) and two troughs at ~370 and ~430 nm (< 5 M-1 cm-1 T-1)
does not resemble either a weak negative feature (a trough at ~420 nm, ~4 M-1 cm-1 T-1)
of ferric HRP or a broadly symmetric derivative-shaped spectral feature (+/- ~15 M-1 cm1

T-1) of ferric Mb. These comparisons suggest the heme group in ferric sGAF2 at pH 7.0

is more likely to be five-coordinate rather than six-coordinate. The MCD spectrum of
ferric sGAF2 at pH 10.0 (gray line) is clearly different from that at pH 7.0 in that one of
the visible region trough (~550 nm) is shifted to ~575 nm and a Soret region feature
becomes derivative-shaped with considerably enhanced intensity (+34/-40 M-1 cm-1 T-1).
The resultant spectral features are indicative of an increased low spin six-coordinate
species.
Dithionite-reduced ferrous state sGAF2 (solid line in Fig. 3.2B) has MCD spectral
features that are broadly similar to those of ferrous Mb (which contains a His-ligated
five-coordinate heme, dotted line in Fig. 3.2B) including quite intense Soret peaks (~125
M-1 cm-1 T-1) except for the more enhanced and derivative-like shape in the visible region
around 555 nm for sGAF2 compared to Mb. At pH 10.0, this derivative-shaped spectral
line becomes much more intense. Concomitantly, the Soret peak intensity diminishes by
~50% (gray line in Fig. 3.2B). These MCD spectral changes are indicative of an increase
in the fraction of a ferrous six-coordinate low-spin heme such as bis-amine (or bis-His)-
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ligated ferrous heme (see below). Fig. 3.3C compares ferric-Im (solid line) and ferricTHT (a cyclic thioether) adducts (dashed line) of sGAF2 with ferric cyt b5 (dotted line).
These three heme adducts display similar MCD spectral patterns, namely relatively
intense derivative-shaped Soret spectra and mainly positive (450 – 560 nm) and negative
(560 – 700 nm) features with a prominent trough at 570 – 580 nm. The MCD spectral
similarity for the ferric-Im complex of sGAF2 and ferric cyt b5, (which contains a bisHis-ligated heme) suggests identical ligation modes for the two heme proteins. Since bisamine- (or bis-His-) and bis-thioether-ligated ferric hemes have been shown to have
similar MCD spectra 20, mono-Im (or His)/mono-thioether-bound ferric heme is expected
also to share the similarity. In Fig. 3.3D, MCD spectra of ferrous-Im and ferrous-THT
adduct are compared with the spectrum of ferrous cyt b5. As seen in their ferric state
(Fig. 3.3C), the MCD spectral patterns of these three ferrous complexes show common
patterns. In the visible region, extremely intense derivative-shaped features around ~555
nm are notable. In the Soret region, the MCD spectra of the THT-bound sGAF2 and cyt
b5 are similar to each other in pattern (except for some intensity difference) while the Imcomplex of sGAF2 shows somewhat different pattern with a noticeably intense trough at
~425 nm. A possible cause of this difference could be incomplete formation of the Imcomplex
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Figure 3.2 MCD spectra at 4 °C of ferric sGAF2 at pH 7.0 (solid line), ferric sGAF2 at
pH 10.0 (gray line; reduced by 2.5 times in the 300-440 nm region), ferric horseradish
peroxidase at pH 7.0 (dashed line), and ferric Mb at pH 7.0 (dotted line) (A) and ferrous
sGAF2 at pH 7.0 (solid line), ferrous sGAF2 at pH 10.0 (gray line; reduced by 2 times in
the 460-700 nm region), and ferrous Mb at pH 7.0 (dotted line) (B) are shown. The
spectra of ferric HRP, ferric Mb, and ferrous Mb are replotted from Ref. 21. Figure
reprinted with permission from Molitor, B., Stassen, M., Modi, A., El-Mashtoly, S. F.,
Laurich, C., Lubitz, W., Dawson, J. H., Rother, M., and Frankenberg-Dinkel, N. (2013) A
heme-based redox sensor in the methanogenic archaeon Methanosarcina acetivorans, J.
Biol. Chem. 288, 18458-18472.
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Figure 3.3 MCD spectra at 4oC of the ferric Im sGAF2 derivative at pH 7.0 (solid line;
with 2mM Im), the ferric THT sGAF2 derivative at pH 7.0 (dashed line; with 14 mM
THT), and 50 mM ferric cyt b5 at pH 7.0 (dotted line) (C) and ferrous Im sGAF2 at pH
7.0 (solid line; with 2 mM Im), ferrous THT sGAF2 derivative in NaPi buffer at pH 7.0
(dashed line; with 14 mM THT), and ferrous cyt b5 at pH 7.0 (dotted line) (D). The
spectra of ferric and ferrous cytochrome b5 are replotted from Ref. 22. See the text for
the types of buffer used for sGAF2, see Ref. 21 for Mb and HRP, and see Ref. 22 for cyt
b5. Figure reprinted with permission from Molitor, B., Stassen, M., Modi, A., ElMashtoly, S. F., Laurich, C., Lubitz, W., Dawson, J. H., Rother, M., and FrankenbergDinkel, N. (2013) A heme-based redox sensor in the methanogenic archaeon
Methanosarcina acetivorans, J. Biol. Chem. 288, 18458-18472..
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In addition to MCD, the Dinkel group also used resonance Raman (RR) for hemeco-ordination determination. In the RR measurements, a six coordinate low spin heme
was observed, whereas MCD data suggests a high-spin state and a five-coordinate
structure rather than a six-coordinate structure. The conditions used in the RR
experiments most likely would not allow detection of a five-coordinate high spin heme
species. Therefore, a clear assignment of the coordination structure cannot be made,
suggesting a mixture of different coordination states. When the pH of the buffer was
changed to pH 10.0, a mixture of a high-spin and low-spin components were also
detectable in MCD spectra, whereas the differences in UV-vis absorption spectra were
minor. This low-spin component appears to be arising from a bis-His-type coordination
structure as judged from the similarity to the Fe(III)-Im complex. Upon reduction of
MA4561 with dithionite, an Fe(II) complex with a broad Soret band at about 432 nm and
a visible band at about 557 nm with shoulders at about 528 and 574 nm is formed. An
additional peak was observed at about 625 nm for the sGAF2 variants. These optical
absorption properties cannot be clearly assigned to one coordination and spin state but
again, rather appear like a mixture of different states. With RR data, a mixture of two
different six coordinate low spin states was observed, and the existence of two species
was confirmed in the MCD measurements. At pH 10.0, one of the two states becomes
predominant as judged from the MCD data and is similar to the bis-His-ligated Fe(II)
form of cyt b5 . The addition of Im or THT for the MCD measurements led to typical six
coordinate low spin hemes for the Fe(III)-(Im and THT) as well as the Fe(II)-(Im and
THT) forms.23,

24

The Im complexes were hardly distinguishable from the THT

complexes with only minor differences in UV-visible as well as MCD spectra.
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Similarities of the Im complexes to cyt b5 led to the conclusion that a His/Im or a
His/THT complex is formed that would resemble a bis-His (cyt b5) or His/Met (many c type cytochromes) ligation structure.
The structural model of sGAF2 generated supports the spectral data with putative
axial ligands in proximity of the heme cofactor. Specifically, two histidine residues
(His702 and His704) are located at the proximal side of the heme pocket that might be
involved in coordinating the heme iron (Fig. 3.4). Initial mutational analyses of these
residues suggest His702 as the proximal ligand (Nicole Frankenberg-Dinkel, unpublished
data). In the distal side of the heme two tyrosine (Tyr632 and Tyr665), one methionine
(Met645), and one histidine (His646) are found. An alternating pair of these groups might
become axial ligands involved in coordinating to the heme iron depending on the redox
state. Because ligands like carbon monoxide (CO), THT, and Im are able to bind to the
heme in MA4561, we envision the distal side of the heme pocket large enough to allow
THT and Im molecules to enter and coordinate to the heme iron. The above mentioned
amino acids might also be involved in stabilizing different ligation states of the heme
without being a direct ligand to the heme iron. Alternatively, they might be exchanged as
a direct ligand upon binding of external ligands as the above spectroscopic data suggest
six-coordinate states also in the absence of external ligands. It is interesting to note that a
cysteine residue (Cys-656) that is speculated to form a covalent bond with the heme is
located near one of the heme vinyl groups, giving the modeled structure more confidence.
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Figure 3.4 Structural model of the heme-binding pocket of MA4561, in the second GAF
domain (aa 608–768) modeled using the PHYRE2 server 25, and the modeled structure is
used to predict putative ligands binding to this structure using 3DLigandSite.26 The heme
cofactor is shown in middle in brown and the protein structure is shown as a green ribbon
(important amino acids are shown as sticks). Figure reprinted with permission from
Molitor, B., Stassen, M., Modi, A., El-Mashtoly, S. F., Laurich, C., Lubitz, W., Dawson,
J. H., Rother, M., and Frankenberg-Dinkel, N. (2013) A heme-based redox sensor in the
methanogenic archaeon Methanosarcina acetivorans, J. Biol. Chem. 288, 18458-18472.
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3.3

Part B: Axial Ligand Determination in Z-ISO
Vitamin A deficiency is a global phenomenon especially in children, causing

blindness, increased susceptibility to disease, and increased mortality.27-29 A sustainable
approach is to provide provitamin A carotenoids in plant food staples to maintain healthy
serum levels of vitamin A, a process currently impeded by the lack of detailed
understanding of the carotegenesis pathway. Dr. Eli Wurtzel’s group (City University of
New York, NY, USA) discovered the 15-cis-ζ-carotene isomerase (Z-ISO), a novel C=C
double bond cis-to-trans isomerase.30 Z-ISO is essential for provitamin A carotenoid
biofortification and for plant adaptation to environmental variation, a significant stress
which affects plant yield. Without Z-ISO, the biosynthetic pathway is blocked.30 In-silico
analysis of this membrane protein led to experimental proof that Z-ISO contains a
nonheme iron and at least one heme-b. It is hypothesized that isomerization in Z-ISO is
regulated by oxidation state of the heme b iron with redox-dependent ligand switching
and a nonheme iron cofactor is indirectly involved. MCD spectroscopy was employed to
test this working hypothesis.
3.3.1 Methods:
Dr. Eli Wurtzel’s group provided us with purified protein samples. MCD spectra
were measured on a Jasco J815 spectropolarimeter fitted with a Jasco MCD-1B magnet at
a magnetic field strength of 1.41 T at 4 °C using a 0.5 cm pathlength quartz cuvette.
Jasco software was used for data acquisition and manipulation as reported previously.19
Concentrations of the heme in Z-ISO samples were determined based on the pyridine
hemechromogen assay method using ε555 = 34.4 mM-1 cm-1.31 Using this method, a value
of ε = 110 mM-1 cm-1 was calculated for the Soret absorption peak (415 nm) of ferric Z79

ISO at pH 7.4. UV-visible absorption spectra were recorded on a Cary 400 spectrometer,
before and after each MCD measurement to track sample integrity. Z-ISO protein
samples were studied in 20 mM Tris buffer containing 20 mM NaCl, 0.2% n-dodecyl-βD-maltoside (DDM), 0.1 mM tris(2-carboxyethyl)phosphine (TCEP) and 5% glycerol at
pH 7.4. The ferrous species of Z-ISO was prepared from ferric protein by flushing a
rubber septum-sealed cuvette with nitrogen gas for about 10-15 min followed by the
addition of a small amount of solid sodium dithionite. The CO adducts of the ferrous
protein were prepared by bubbling the CO gas in to the reduced protein.
3.3.2 Results and Discussion:
MCD and UV-vis absorption spectra of ferric state of Z-ISO are shown in Fig.
3.5, overlaid for comparison with that of a simulated spectra consisting of 50% ferric cyt
b5 and 50% imidazole (Im)-bound P450-CAM. The spectra (MCD and UV-Vis) of the
ferric Z-ISO (solid red line in Fig. 3.5) overlaps very well with the simulated spectra
(dashed blue line in Fig. 3.5) of ferric cyt b5 (bis-His axial ligands) and Im-bound P450CAM (His-Cys axial ligand pair). This indicates that the heme(s) in ferric Z-ISO appear
to have two sets of ligand pairs (His-His and His-Cys) in a ~1:1 ratio, either as a single
species (with a common His) or as two separate heme centers.
MCD and UV-vis absorption spectra of the ferrous state of Z-ISO are shown in
Fig. 3.6, with analogous states of mono imidazole [H93G mono(Im)-Mb] and bis
imidazole [H93G bis(Im)-Mb] bound H93G-myoglobin mutant are overlaid for
comparison. The MCD spectral pattern of dithionite-reduced Z-ISO (red solid line in Fig.
3.6) is similar to that of ferrous H93G bis(Im)-Mb (blue dashed line in Fig. 3.6) which
has a (His-His) coordination, indicating a ligand switch from a His-His or His-Cys
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coordination in oxidized state to a single His-His coordination in the reduced state. MCD
and UV-vis absoprtion spectra of the CO-bound ferrous state of Z-ISO are shown in Fig.
3.7, (calculated for 100% CO saturation, red solid line in Fig 3.7) with those of
cyclohexylamine-bound H93G myoglobin (H93G-(CHA) Mb) (blue dashed line in Fig
3.7) and wild type sperm whale myoglobin (Mb) (black dotted line in Fig 3.7) overlaid
for comparison. The formation of the ferrous-CO complex did not appear to be complete
even after extensive CO bubbling, judging from the double MCD troughs at ~555 and
~565 nm. Thus, we have tried to obtain spectra of the CO-saturated form by calculation
assuming that the observed MCD spectrum was for incompletely CO-saturated ferrous ZISO. The best estimate for CO saturation was 70% CO-bound form in CO-bubbled ZISO. The MCD line shapes and spectral intensities (for main peaks and troughs) are
roughly similar for the three proteins. MCD spectra of ferric Z-ISO show that the heme
has two ligand pairs (His-His and His-Cys). This was determined by comparing the ZISO spectrum with that of a simulated mixture of Cyt b5 (bis-His heme coordination) and
imidazole (Im)-bound P450-CAM (His-Cys heme coordination) (Fig. 3.5). Thus, there
appear to be two ligand coordination modes in low spin ferric Z-ISO in ~ 1:1 ratio. It
appears that if there is only one heme center in the protein, His and Cys might occupy the
distal side of the heme as alternative endogenous ligands while the proximal side is
ligated by a common His. However if two heme centers exist, there should be two
separate proximal histidines.
To help distinguish among the alternate hypotheses, we probed the MCD
spectrum of the dithionite-reduced Z-ISO. We found that there is a single heme species in
the reduced Z-ISO which shows only the bis-His species (Fig. 3.6). The data suggest that
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the heme may be undergoing ligand switching when the protein is reduced. A small
fraction of high-spin heme b that is His-ligated and five coordinate was also detected,
which may represent an intermediate. The MCD spectra of CO-bound Fe(II) Z-ISO also
showed only about 70% CO saturation (Fig. 3.7), suggesting that while the distal His
ligand is weak, it is not completely replaced by exogenous ligand.
Based on these data, a working hypothesis is proposed that an inactive Z-ISO
carries an oxidized heme Fe(III), where cysteine blocks substrate access to the iron in the
active site. Reduction of the heme switches coordination of the heme to bis-His, thus
exposing the active site for substrate access to the heme Fe(II). A schematic
representation of the heme ligand switching is summarized in below Scheme 3.1.
ﬁve coordinate
High spin

six coordinate
Low spin

six coordinate
Low spin

Cys

His

FeIII

His

FeIII

FeIII

His
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FeII
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FeII
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His

His

Scheme 3.1 Schematic representation of the heme ligand switching in Z-ISO.
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Figure 3.5 MCD and UV-vis absorption spectra at 4 °C of ferric Z-ISO at pH 7.0 (solid
red line), overlaid with simulated spectra consisting of 50% ferric cyt b5 and 50% ferric
Im-bound P450-CAM (blue dashed line). The simulated spectra are replotted from
individual spectra in Refs. 22 and 32 respectively
.
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Figure 3.6 MCD and UV-vis absorption spectra at 4 °C of ferrous Z-ISO at pH 7.0 (solid
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Figure 3.7 MCD and UV-vis absorption spectra at 4 °C of CO-bound ferrous Z-ISO
calculated for 100% saturation at pH 7.0 (solid red line), with H93G-(cyclohexylamine)
Mb (blue dashed line) and wild type (WT) Mb (black dotted line). The spectra of ferrousCO H93G-(cyclohexylamine) Mb (UV-Vis data: Dawson, J. H., Kadkhodayan, S.,
Zhuang, C., Sono, M., unpublished data), and WT Mb spectra are replotted from Refs. 33
and 34 respectively
.
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3.4

Part C: Demonstration of Oxy-ferrous Heme Adduct Formation in

Ruthenium-diimine Photosensitizer Modified P450-BM3
Cytochrome P450 enzymes are capable of hydroxylating unactivated C-H bonds
with the help of molecular dioxygen and reducing equivalents at ambient temperature and
physiological pH with a high catalytic efficiency. This synthetic ability makes them
particularly attractive for biotechnological applications; however complete dependence of
the reactions on NAD(P)H and the reductase domain for electron transfer impedes their
use as bio-catalysts. Amongst the numerous attempts to circumvent this issue, Dr. Lionel
Cheruzel’s lab (San Jose State University, San Jose, CA) has developed a series of hybrid
enzymes using P450-BM3 (CYP102) and photosensitizer that could be activated using
light. These hybrid enzymes consists of Ru(II)-diimine photosensitizer, covalently
attached to non-native single cysteine residue close to the P450 BM3 heme domain.35
Photoactivation converts the Ru(II) into a highly reductive Ru(I) species which provides
the two necessary electrons to the heme domain in successive one-electron transfer
steps.36 Introduction of these mutations and/or covalent attachment of the Ru(II)
photosensitizer does not significantly alter the binding of lauric or palmitic acid.
Particularly the Ru(bpy)2phenA (bpy= bipyridine and phenA= 5-acetamido-1,10
phenanthroline) modified L407C mutant of P450-BM3 was found to have a high turnover
number in the hydroxylation of lauric acid. In order to ascertain the ability of the hybrid
enzyme to form the oxy-ferrous intermediate, Dr. Cheruzel’s lab collaborated with our
lab to use MCD spectroscopy to examine the integrity of the oxyferrous intermediate.
3.4.1 Methods:
Dr. Lionel Cheruzel provided us with purified protein samples of wild type (WT)
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and L407C-Ru-diimine hybrid sample prepared as described in

37

. MCD spectra were

measured on a Jasco J815 spectropolarimeter fitted with a Jasco MCD-1B magnet at a
magnetic field strength of 1.41 T at 4 °C and -50 °C in a mixed solvent (see below) using
a 0.5-cm-path length quartz cuvette. Jasco software was used for data acquisition and
manipulation as reported previously.19 Concentrations of the P450-BM3 L407C-Rudiimine hybrid sample were determined based on a value of ε = 104mM-1 cm-1 for the
ferric protein. UV-vis absorption spectra were recorded on a Cary 400 spectrometer,
before and after each MCD measurement to track sample integrity. Sample preparation
and data collection was done as previously described in Ref. 38, and in complete detail in
39

. The L407C-Ru-diimine hybrid sample was analyzed in a buffer comprising of 0.3 M

Tris at pH 8.0 and glycerol in a starting ratio of 30/70 (v/v), with the final concentration
of glycerol in the protein sample being ~60% (after some dilution with dithionite aqueous
solution). Before adding sodium dithionite, the sample was degassed over 3 h on ice with
a slow stream of nitrogen gas in a rubber septum-sealed cuvette to ensure complete and
highly anaerobic condition.
3.4.2 Results and Discussion:
We examined the oxy complex of P450-BM3 L407C-Ru-diimine hybrid sample
in cryo-solvent in both the presence and absence of substrates. The oxy complex of the
Ru-diimine labeled protein was made by bubbling O2 in the reduced protein (dissolved in
~65% glycerol solution) at -50o C. The P450-BM3 L407C-Ru-diimine hybrid (solid red
line in Fig. 3.8) forms a stable oxy-complex at -50o C whose MCD and UV-Vis
absorption spectra are very similar to the O2 adduct of wild-type P450 BM3 (blue dashed
line in Fig. 3.8) as well as bacterial wild type P450-CAM (black dotted line in Fig. 3.8).
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The O2-bound Ru-diimine labeled as well as WT P450-BM3 may be stable even at
slightly higher temperatures (such as -30o C), but we have not examined the temperature
dependence of its stability in this work. MCD and UV-vis absorption spectra of lauric
acid (LA) and palmitic acid (PA)-bound P450-BM3 L407C-Ru-diimine hybrid (pink
solid line and green solid line in Fig. 3.9) show that they form a stable oxy-complex just
like the Ru-diimine labeled protein (red dotted line in Fig. 3.9) at -50oC. Their MCD and
UV-Vis absorption spectra are very similar to those of the O2 adduct of the substrate-free
enzyme, as seen in Fig. 3.9. With LA and PA substrates, we did not observe a marked
conversion from low-spin species to high-spin species on substrate addition in the ferric
protein in 60-70% glycerol buffer as is seen in aqueous buffer. We initially thought this
was resulting from incomplete binding of the substrate although similar results have been
reported earlier by Dawson and co-workers.38 Thus we set out to test another substrate Npalmitoylglycine (NPG) that has been shown to bind P450-BM3 with a low Kd value.40
We observed that conversion to a high-spin form spectrum upon substrate binding to
ferric enzyme (low spin) is not pronounced in the 70:30 Glycerol/Tris buffer (pH 8).
However, nearly complete conversion to a high-spin state can be clearly seen in the 50
mM Tris, pH 7.2 buffer (without glycerol) at room temperature (~22 oC) (blue dashed
line in Fig. 3.10). Analogous P450-CAM spectra with and without the substrate camphor
are overlaid for comparison in Fig. 3.10. Just like the other substrate containing samples,
the oxy complex of the Ru-diimine labeled protein was made by bubbling O2 in the
reduced protein in ~65% glycerol solution (the initial 70/30 Glycerol/0.3M Tris buffer,
pH 8.0 was slightly diluted by dithionite stock solution added to reduce the ferric
protein),
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Figure 3.8 MCD and UV-Vis absorption spectra of the O2 adduct of the P450-BM3
L407C-Ru hybrid (blue dashed line), wild-type P450 BM3 (blue dashed line) as well as
bacterial wild-type P450CAM (black dotted line) recorded at -50oC in ~60% glycerol
containing 0.3 M Tris buffer at pH 8.0. The spectra of ferrous di-oxy P450CAM are
replotted from Ref. 41
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Figure 3.9 MCD and UV-Vis absorption spectra of the O2 adduct of the substrate-free
P450-BM3 L407C-Ru hybrid (red dotted line), LA-bound form (pink solid line) as well
as PA-bound form (green solid line) recorded at -50oC in ~60% glycerol containing 0.3
M Tris buffer at pH 8.0
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Figure 3.10 MCD and UV-Vis absorption spectra of the ferric substrate-free P450-BM3
L407C-Ru hybrid (red solid line), ferric NPG-bound form (blue dashed line) as well as
ferric substrate-free P450-CAM form (black dotted line) and ferric camphor-bound P450CAM (pink dashed line) recorded in aqueous buffer. The spectra of ferric substrate-free
P450-CAM and ferric camphor-bound P450-CAM MCD are replotted from Ref. 42
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Figure 3.11 MCD and UV-Vis absorption spectra of the O2 adduct of the substrate-free
P450-BM3 L407C-Ru hybrid (red solid line), NPG-bound form (blue dashed line) as well
as camphor-bound P450-CAM (black dotted line) recorded at -50oC in ~60% glycerol
containing 0.3 M Tris buffer at pH 8.0. The spectra of oxy-ferrous camphor-bound
P450CAM spectrum is replotted from Ref. 41.
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solution at -50 oC. While the NPG-bound protein forms a comparable oxy-complex just
like the substrate-free Ru-diimine-labeled protein at -50 oC, as seen in Fig. 3.11 the oxyP450BM3-Ru + NPG complex appeared to be less stable than the oxy-complex without
substrate or with LA or PA even at –50 oC. This was judged from the gradual MCD
spectral changes (to the ferric state) upon O2 bubbling into the deoxyferrous form at –50
o

C compared with little spectral changes during the same treatments and time periods for

substrate-free and LA- or PA-bound P450BM3-Ru-diimine proteins. In fact, the Soret
MCD peak and trough intensities for the NPG-bound oxy-P450BM3-Ru are somewhat
higher than the other samples, which is a sign of ferric form contamination.
3.5

Part D: Heme Axial Ligand Determination in Phu_R
The Phu_R is a TonB dependent outer membrane receptor that is part of the

Pseudomonas heme uptake system from Pseudomonas aeruginosa.43 Phu_R helps in the
transport of heme to the periplasm from where a further cascade helps in retrieval of iron
(an essential micronutrient for survival and virulence of bacterial pathogens) from the
heme.44,

45

Sequence alignments of TonB dependent outer membrane receptors have

shown that heme is coordinated through two histidine residues, however, a conserved
histidine observed on the extracellular FRAP loop of other receptors is missing in Phu_R.
There are other potential ligands present in the vicinity, specifically His-102, Tyr-519,
Tyr-529 and His-530. To confirm the correct identity of the heme coordinating ligands
Dr. Angela Wilks (University of Maryland, Baltimore, MD) collaborated with our lab to
conduct MCD experiments on the WT and mutant enzymes.
3.5.1 Methods:
Dr. Angela Wilks provided us with purified samples of WT and mutant Phu_R
93

proteins Y529A, Y529H and H102A (data unpublished). MCD spectra were measured on
a Jasco J815 spectropolarimeter fitted with a Jasco MCD-1B magnet at a magnetic field
strength of 1.41 T at 4 °C using a 0.2 cm pathlength quartz cuvette. Jasco software was
used for data acquisition and manipulation as reported previously.19 Concentrations of the
samples were tentatively determined (based on the pyridine hemochromogen method) for
the Soret absorption peaks of ferric WT Phu_R (ε405 = 96.9 mM-1 cm-1), Y529A Phu_R
(ε404 = 114.0 mM-1 cm-1) and Y529H Phu_R (temporary value of εSoret = 100 mM-1 cm-1).
UV-vis absorption spectra were recorded on a Cary 400 spectrometer, before and after
each MCD measurement to track sample integrity. Phu_R protein samples were studied
in 50 mM Tris pH 7.5, 50 mM NaCl, and 0.06% (w/v) lauryldimethylamine-oxide
(LDAO) at pH 7.5. The imidazole (Im) and cyanide (CN¯) adducts were prepared by
adding aliquots of Im and KCN stock solutions (1 M or diluted concentrations, pH
adjusted to ~7) to the protein, respectively, until apparent saturation (no further spectral
change) was reached. The ferrous species of Phu_R prepared from the ferric protein in
the presence of exogenous ligands, by flushing a rubber septum-sealed cuvette with
nitrogen gas for about 10-15 min followed by the addition of a small amount of solid
sodium dithionite was found to denature the sample. Thus, for the purpose of this study
we only looked at ferric forms of the protein.
3.5.2 Results and Discussion:
We have examined the Phu-R protein (enzyme) along with its mutants, with
magnetic circular dichroism (MCD) and UV-visible (UV-Vis) absorption spectroscopy in
its ferric [Fe(III)], ferric + cyanide [Fe(III)-CN] and ferric + imidazole [Fe(III)-Im] bound
states. The spectra of PhuR are overlaid with those previously reported for the
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corresponding states of legehemeglobin-A + phenol, cytochrome b5 (bis-His-ligated
heme protein), mono-4-methylimidazole (4-MeIm)-bound H93G Mb (proximal cavity
Mb mutant), bis-His bound H93G Mb, and wild type myoglobin (WT-Mb), for
comparison. The MCD spectral pattern of ferric WT PhuR as seen in Fig 3.12 (red solid
line) is somewhat similar in both the Soret (350 - 450 nm) and visible regions (450 - 700
nm) to that of phenol-bound ferric leghemoglobin a (Lb-a) (black dashed line in Fig.
3.12) which has a proximal His and distal phenol (Tyr equivalent) heme ligation. This
strongly suggests that ferric WT PhuR has His-Tyr type of heme ligation. Judging from
the slightly larger MCD trough intensities at ~570 and ~420 nm, Fe(III) WT PhuR
appears to contain more low-spin component than phenol-bound Lb-a. When the MCD
and UV-vis absorption spectra of Fe(III) WT PhuR was titrated with cyanide as seen in
Fig. 3.13, a spectral shift of 6 nm was observed on apparently saturation (Kdapp ~ 39.7
μM). However, the incomplete conversion of the ferric heme to low-spin (remaining
absorption peak at ~620 nm and MCD trough at ~630 nm) indicates that the heme is not
totally converted to a cyanide complex (100% low-spin species).
The MCD and UV-Vis absorption spectral patterns of ferric Y529A PhuR as seen
in Fig. 3.14 shows the presence of charge-transfer UV-Vis spectral bands at ~610 and
~490 nm, an MCD trough at ~630 nm and relatively small MCD peak to trough intensity
in the Soret region. This indicates that ferric Y529A PhuR protein (red solid line in Fig.
3.14) heme is high-spin; however, its MCD/UV-Vis absorption spectra do not resemble
those of meta-aqua Mb (black dotted line in Fig. 3.14) or mono-4-methylimidazolebound H93G Mb (blue dashed line in Fig. 3.14) well, although broad similarities may be
found.
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Figure 3.12 MCD and UV-vis absorption spectra of ferric WT PhuR (red solid line)
overlaid for comparison with phenol-bound ferric Lb-A (black dashed line). The Lb-A
spectra are replotted from Ref. 46
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Fe(III) Phu_R WT + KCN in Tris-NaCl Buffer pH 7.5 @ 4oC
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Figure 3.13 MCD and UV-vis absorption spectra of ferric WT PhuR (red solid line)
overlaid for comparison with CN-bound ferric WT Phu_R (blue dashed line).
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Figure 3.14 MCD and UV-vis
Y529A PhuR protein (red
solid line) overlaid for comparison with that of meta-aqua Mb (black dotted line)
replotted from Ref. 21 (UV-Vis data: Dawson, J. H., Kadkhodayan, S., Zhuang, C., Sono,
M., unpublished data) and mono-4-methylimidazole-bound H93G Mb (blue dashed line)
replotted from Ref. 47.
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Fe(III) Y497A in Tris-NaCl Buffer pH 7.5
with KCN and Im @ 4oC
20

MCD

10
-1

20

0

0

-20

/H (M cm T)

/H (M cm T)

-1

40

-10

-40
-20
25

150
UV-Vis

20

418

541

15
533
611

10

50

-1

100

411

(mM cm)

(mM cm)-1

407

5

0
300

400

500

600

0
700

Wavelength (nm)
Fe(III)-Im Y497A Phu_R
Fe(III)-CN Y497A Phu_R
absorption
spectra
of ferric
Fe(III) Y497A
Phu_R

Figure 3.15 MCD and UV-vis
Y529A Phu_R protein (red
solid line) overlaid for comparison with and Im- adducts of ferric Y529A Phu_R (black
dotted line) and (blue solid line), respectively.
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Fe(III) Phu_R Y497H in Tris-NaCl Buffer pH 7.5,
Cytochrome b5 and H93G bis-Im @ 4oC
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In addition, a noticeable MCD shoulder at ~380 nm is observed for the Fe(III)
Y529A PhuR. KCN and Im titrations of ferric PhuR Y529A as seen in Fig. 3.15 resulted
in formation of the respective ligand complexes of this mutant exhibiting Soret
absorption peak shifts from 407 nm to 411 nm (Im) and 418 nm (CN-) and appearance of
low-spin type visible region absorption peaks at ~533 nm (Im) and ~540 nm (CN-). Soret
MCD peak-to-trough intensities also increase by more than two-fold for both ligands as a
sign of formation of low-spin complexes. However, similar to the case of WT Fe(III)
PhuR (Fig. 3.13), the high-spin charge-transfer band at ~610 nm does not disappear
completely as well as the remaining MCD trough at ~630 nm for the both ligands. Thus,
ligand complex formation seems to be incomplete, especially for the cyanide adduct that
should be totally low-spin.
The MCD spectral pattern of ferric Y529H PhuR as seen in Fig 3.16 (green solid
line) overlaps essentially perfectly in both the Soret (350 – 450 nm) and visible regions
(450 – 700 nm) to that of ferric cyt b5 (red dashed line) and bis-imidazole bound H93G
Mb (black dotted line), both of which have bis-His (Im) heme ligation, clearly suggesting
that Y529 to H mutation imparts a bis-His ligation to the heme.
3.6

Conclusion:
We have analyzed the sGAF2, Z-ISO, P450-BM3 L407C-Ru hybrid sample and

Phu_R heme proteins with MCD and compared their spectra against data from the heme
protein spectral library recorded and maintained by our lab. In the case of sGAF2, Z-ISO
and Phu_R proteins, MCD helped in identification of the heme coordinating ligands,
whereas in the case of P450-BM3 L407C-Ru-diimine hybrid, MCD was used to
characterize the ferrous dioxygen complex. Knowledge of the heme ligand identity has
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been used to hypothesize a working mechanism for the Z-ISO enzyme. For the P450BM3 L407C-Ru-diimine hybrid, the MCD characterization of the ferrous dioxygen
intermediate was used to ascertain that the engineered enzyme was following a normal
P450 turnover pathway. The fingerprinting ability of MCD coupled with other
spectroscopic techniques such as resonance Raman and EPR makes it a valuable tool in
investigating the structure and function of novel heme enzymes.
3.7
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